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Abstract 
Cancer is one of the leading causes of death in developed countries and rising fast as a 
cause of death in developing countries. The increase of cancer prevalence in developing 
countries can be attributed to westernisation trends, with lifestyle cancers such as colorectal 
and lung cancer being amongst the most commonly reported malignant neoplasms. This 
means that the development of novel methods of treatment is essential in combatting this 
disease in the developing world. Combinational chemotherapy is one of the best candidates 
for treatment, but it is reliant on effective compounds targeting different modes of action. It 
also means that these compounds should be easily and cheaply available. 
Makaluvamines have been identified as a class of compounds that may have a novel mode 
of action on top of being known as topoisomerase II inhibitors. This study attempted to 
devise a short and concise synthetic strategy, based on reported procedures, to construct 
makaluvamine C analogues. This involved the introduction of a methyl group to an indole 
intermediate (7,8-dimethoxy-1,3,4,5-tetrahydropyrrolo[4,3,2-de]quinoline), before oxidation to 
a quarternized pyrroloiminoquinone (7-methoxy-5-methyl-8-oxo-1,3,4,8-
tetrahydropyrrolo[4,3,2-de]quinolin-5-ium chloride). The introduction of this methyl group 
proved problematic, as the indole substrate proved to be difficult to handle and tended to 
degrade under reaction conditions. The lack of initial success prompted the deviation from 
the initial route by quarternizing a quinoline intermediate to form a quinolinium iodide salt (4-
(dimethoxymethyl)-6,7-dimethoxy-1-methyl-5-nitroquinolin-1-ium iodide). Upon reduction to 
give 4-(dimethoxymethyl)-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroquinolin-5-amine, it was 
discovered that the subsequent ring-closing reaction to produce 7,8-dimethoxy-5-methyl-
1,3,4,5-tetrahydropyrrolo[4,3,2-de]quinoline was still problematic. 
The synthesis of the target compounds has not yet been successfully completed, but will still 
be pursued so these compounds can be evaluated for their anticancer activity and have their 
mode of action tested.  
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Uittreksel 
Kanker lewer van die grootste bydrae tot mortaliteit in ontwikkelde lande en is vining aan die 
toeneem in ontwikkelende lande. Die toename van kanker voorvalle in ontwikkelende lande 
kan toegedra word aan die verwesteringstendens, met kankers soos kolo-rektale- en long 
kanker onder die mees algemene kwaadaardige neoplasmsas wat aangemeld word – 
kankers wat gekoppel word aan leefstyl keuses. Dit beteken dat daar ‘n dringende nood is 
aan nuwe metodes van behandeling van die siekte in ontwikkelende lande. Kombinasie 
chemoterapie is een van die beste kandidate vir behandel, sienende dat dit gebruik maak 
van middels was verskillende aspekte van die siekte uitbuit. Om effektief te wees, moet die 
antikanker middels goedkoop en maklik beskikbaar te wees. 
Makaluvamines is geïdentifiseer as ‘n klas van antikanker middele wat moontlik ‘n nuwe 
metode van inhibisie het, tesame met hul topoïsomerase II inhibisie. Hierdie study het 
daarom gepoog om ‘n korter en meer bondige sintetiese roete saam te stel, wat gebaseer is 
op literatuur prosedures, om analoeë van makaluvamine C te produseer. Dit het die 
aanhegging van ‘n metiel group aan ‘n indool tussenproduk (7,8-dimetoksie-1,3,4,5-
tetrahidropirolo[4,3,2-de]kinolien) behels, gevolg deur die oksidasie tot die kwaternêre 
piroloiminokwinoon (7-metoksie-5-metiel-8-oxo-1,3,4,8-tetrahidropirolo[4,3,2-de]kinolin-5-ium 
chloried). Om hierdie metiel groep aan te voeg was, nietemin, problematies, aangesien die 
indool produk moeilik was om te hanteer sienende dat dit onder reaksie toestande 
gedegradeer het. Die aanvanklike onsuksesvolle pogings het daartoe gelei dat die sintetiese 
roete herdink was en is aangepas om eerder gebruik te maak van ‘n kinolinium jodied sout 
(4-(dimetoksiemetiel)-6,7-dimetoksie-1-metiel-5-nitrokinolin-1-ium jodied). Die reduksie van 
hierdie sout en agtereenvolgende annulasie reaksie om 7,8-dimetoksie-5-metiel-1,3,4,5-
tetrahidropirolo[4,3,2-de]kinolien te vorm was egter steeds problematies. 
Die sintese van die beoogde produkte was tot dusver nog nie suksesvol nie, maar sal egter 
steeds aangedurf word om hulle ten einde suksesvol te sintetiseer en dan te stuur om hulle 
biologiese eienskappe te toets. Dit sluit hulle antikanker aktiwiteit in asook hul metode van 
inhibisie. 
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Chapter 1 
1.1 Introduction 
Cancer is caused when there are mutations in genes with high cancer susceptibility, such as 
oncogenes and tumour-suppressor genes (TSGs), and genes that generally cause genetic 
instability.1 It is currently one of the largest diseases worldwide, with 12.7 million new cases 
of various cancers reported in 2008, according to a world cancer factsheet published by 
Cancer Research UK in conjunction with the World Health Organization.2 According to this 
factsheet, 40% of these newly reported cases were lung, female breast, colorectal and 
stomach cancers. The deaths reported due to the various cancers in 2008 amounted to 13% 
of the total global deaths at a number of 7.6 million deaths.2 On top of these statistics, 
cancer is also set to become an even bigger challenge to overcome in the next 16 years, 
with the global population expected to rise to approximately 8.3 billion by 2030. The 
predicted number of new cases is then expected to be around 20.3 million cases and 13.2 
million deaths.2  
Cancer used to be a more predominant cause of death in high-income countries, but the 
trends suggest that it will become just as large a cause of mortality in medium to lower 
income areas.3 Cancer Research UK reported that 47% of new cancer cases and 55% of 
cancer deaths are from the less developed countries or regions – countries with a low or 
medium Human Development Index (HDI). HDI is an index of three components: life 
expectancy at birth, educational attainment and income. Countries are classified into four 
levels of HDI by the United Nations Development Programme. Only 5 African countries fall 
into the high HDI category as of 2014 and the majority of the other countries are in the low 
human development category.4 The International Agency for Research on Cancer (IARC) 
reported that 715 000 new cases were reported in Africa along with 542 000 deaths.5 This is 
close to 6% of the global total in new cases and just over 7% in global deaths when 
considering the statistics given by Cancer Research UK.2 These numbers are, 
conservatively, considered to double by 2030 due to the increases in so-called 
“westernisation” – the lifestyles and diets associated with economic development.2,6  
As it stands, cancer is still considered a lower priority in comparison with diseases such as 
tuberculosis, malaria and the biggest pandemic in terms of number of people infected, 
acquired immune deficiency syndrome (AIDS) brought on by the human immunodeficiency 
virus (HIV).6 HIV/AIDS was the leading cause of death in Africa in 2004, contributing 13.3% 
to the total death toll, whereas it ranked only 8th worldwide (3.5% of the total number of 
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deaths recorded). Almost the inverse of these statistics are seen when comparing the 
contribution of malignant neoplasms to the death toll. Malignant neoplasms accounted for 
12.6% of recorded deaths in worldwide in the same year, but only 4.5% of deaths in Africa. 
The occurrences of cancer and the prevalence of the different types thereof, differ greatly 
when comparing Africa to a continent with an HDI ranging from high to very high such, as 
North America.6 The types of cancers present in these high to very high HDI countries are 
more lifestyle related, cancers such as lung cancer brought on by tobacco and colorectal 
cancers exacerbated by obesity and a high consumption of fast food. A decrease in physical 
activity that generally accompanies economic development also strongly contributes to the 
high number of colorectal cancers reported. The ‘westernization’ trend of developing 
countries such as those in Africa are showing increases in the number of reported cases of 
these lifestyle-associated cancers.6  This means that as the developing countries strive to 
increase their HDI level, an increase in reported cancers will also be seen. 
It is imperative that, since the statistics mentioned above suggest a definite increase in 
sufferers from non-communicable diseases like cancer, novel methods of combatting these 
diseases are developed along with refining and improving upon the current treatments. 
Chemotherapy has long been used to combat cancer and other diseases. The broad 
definition of chemotherapy is the use of artificial remedies to treat specific infections, as 
published by Dale in Science in 1924. According to Dale, the aim of chemotherapy is to find 
new remedies and improve upon existing ones to suppress a specific infection rather than 
simply treating the symptoms.7 
Chemotherapy as a method of treatment for cancer started in the early 1940’s with Louis 
Goodman and Alfred Gilman, who used nitrogen mustard to treat non-Hodgkin’s lymphoma. 
This stemmed from their analysis of the autopsy reports on soldiers that died during the First 
World War due to exposure to some of the chemical warfare agents used in that time. These 
soldiers exhibited lymphoid hypoplasia as well as myelosuppression, two conditions that 
Goodman and Gillman postulated could be induced – by controlling the administered dosage 
of the chemical agents – in certain tumour types as well. They indeed found it to be the case 
in the lymphoid tumours transplanted into mice. The tumour growth was not only stopped, 
but showed regression.8 Continued studies by these researchers also suggested that tumour 
cells were more sensitive to toxins than healthy cells, which lead to probes into compounds 
that induce apoptosis.8 All of this lead to what is considered the dawn of modern 
chemotherapy -  the work of Hitchings and Ellion on antileukemic drugs.9 Their research 
demonstrated that these antileukemic agents inhibited cell proliferation via the interference 
with early stages in RNA and DNA synthesis of the tumour cells.9 
Stellenbosch University  https://scholar.sun.ac.za
3 
 
In the treatment of other diseases, such as tuberculosis and sub-acute bacterial 
endocarditis, combinations of drugs in a single treatment were already commonplace, as the 
different drugs targeted different sites of action in the disease. This was termed combination 
chemotherapy and in the case of cancer - even in the early stages of chemotherapy, the 
same principle seemed to apply as the treatment of a tumour with a single antiproliferative 
agent was rarely very effective.10 Frei and co-workers stated that the combination of a 
minimum of three active anticancer agents are necessary to effectively cure a certain 
cancer.11  An active anticancer agent is a compound which can produce a minimum 
response rate of 30% when used in isolation for the treatment of a certain type of cancer. 
The reason cited for this was that it overcomes the drug resistance of the tumours due to the 
multi-pronged treatment.10 Peters et al. noted that this combination of various 
antiproliferative agents and development of methods to test the efficacy of these 
combinations have led to the treatment of tumour types that were previously considered 
untreatable.12 Another advantage of combination chemotherapy is that the percentage of 
complete remission of certain cancer types were much higher under this method of 
treatment was much higher than when a single antiproliferative agent was used. This was 
reported by Frei and co-workers in a study of the combination of chemotherapeutic agents 
along with radiation therapy. Complete remission was observed in 12 of their 14 patients, 9 
of which remained in remission.11 
Though the combination of anticancer agents is beneficial, there is also the toxicity of these 
compounds to consider. Chemotherapeutic treatments should increase the lifespan and, 
more importantly, the quality of life of the patient. This is where many of even the most 
promising antiproliferative compounds come short, as the benefits of the treatments are 
sometimes counteracted by the toxicities and side-effects of these compounds. The toxicity 
innate to all anticancer agents is due to the fact that normal cells with rapid cell proliferation 
are just as susceptible to these compounds as the cancerous cells that are the intended 
targets. This makes the selection and combination critical.13  
Extending on the work initially done by Frei and co-workers,10 Bertino and co-workers 
reported the successful use of combination chemotherapy to treat large cell lymphomas.14 
The researchers reported a high degree of success in the treatment of patients using 
combination sequential chemotherapy, with 5 out of 8 patients diagnosed with diffuse 
histiocytic lymphoma remaining in remission for periods between 55 and 65 months.14 The 
successes thus far relied on the use of a handful of efficient antiproliferative agents and 
combinations of these compounds to sensitize and treat these malignant neoplasms. This 
called for the development of new and more efficient anticancer agents, but the field was 
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considered high risk due to the small returns on research products, as new compounds 
proved either ineffective or too costly to produce.8 
In the two decades following 1975, fewer than 10% of the newly developed anticancer drugs 
entering clinical trials were approved by the Food and Drug Administration (FDA) of the 
United States. Von Hoff cited three main reasons for the low success rate of newly 
developed compounds: high toxicity of the new anticancer agents; compounds showing no 
efficacy; and poor understanding of the mechanism of action of the new compounds when 
the clinical trials were designed.15 The progress in chemotherapy development slowed down 
markedly by the mid 1980’s, due to no marked improvement on older compounds by novel 
chemotherapeutic agents and only limited success on large, long term trials. Another issue 
was the models used for testing, as the success in the animal models utilized, did not 
translate into clinical success. This prompted the development of the National Cancer 
Institute’s (NCI) 60 human tumour cell line screen.8 
This new screen has not been markedly more successful than the previous models in the 
identification of new lead compounds, but it has given a benchmark for the comparison of 
new compounds. It does, however, not aid in the identification of new mechanisms of tumour 
growth inhibition, as all new compounds discovered in these screens are generally 
antimitotic agents or topoisomerase I and II poisons.8 However, to exploit these 
mechanisms, the basis of all malignant neoplasms need to be understood. Hanahan and 
Weinberg identified six biological characteristics that offer more insight into the progression 
of tumour development. These six characteristics are acquired as a normal cell progressed 
to a tumour cell. The six characteristics, as they are named by Hanahan and Weinberg, are: 
sustaining proliferative signalling; resisting cell death; inducing angiogenesis; enabling 
replicative immortality; activating invasion and metastasis; and lastly, evading growth 
suppressors.16 By understanding the mechanism of action of new anticancer compounds, 
the biological pathways and mechanisms that give rise to these six characteristics could be 
targeted to inhibit cell proliferation. 
As mentioned, the constant improvement of combination chemotherapy needed more lead 
compounds and the biosphere has proven to be a great source of new pharmaceutical 
leads.17,18 This will be discussed in more depth in the following section (Section 1.2), where 
more background on the natural products – the makaluvamines - that served as inspiration 
for this study, will be given. Following the discussion on the makaluvamines, the mechanism 
of action of these compounds will be discussed. As Von Hoff reported, finding novel 
mechanisms of action could be the highly advantageous in developing more potent clinical 
trials. The mechanism by which these compounds, the makaluvamines, inhibit cell 
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proliferation will then be discussed in Section 1.3, with attention being paid to the 
mechanisms suggested by Zhang and co-workers.19  
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1.2 Background 
The importance of natural products in the discovery of biologically active compounds has 
been highlighted by the large percentage of cancer drugs that are based on natural 
compounds.17 A review  by Newman and Cragg on cancer compounds used from 1981 to 
2010 showed that close to half (48.6%) of the compounds used in treatment are natural 
product related.18 Marine sources have been a major source of these compounds, with the 
biologically relevant products existing as secondary metabolites in a variety of marine 
invertebrates. Considering that the oceans make up about 95% of the planet’s biosphere, 
they do present a possible endless source of biologically viable compounds. This is due to 
the inherent defence mechanisms of these creatures against predation or adaptation to 
limited resources.20 These invertebrates include sponges, bryazoa, tunicates and ascidians, 
with sponges being the greatest source of novel structures.21  
Makaluvamines are alkaloid metabolites that share a general skeleton structure with a 
variety of other marine alkaloids from the Latrunculiidae and Acarnidae families of marine 
sponges.22 The sponges of the Latrunculiidae family are common in the cold coastal waters 
of Antarctica, New Zealand, Australia, Tasmania and South Africa.23 The general structures 
found in this family are pyrrolo[4,3,2-de]quinoline 1, pyrrolo[4,3,2-de]pyrrolo[2,3-h]quinoline 
2, pyrido[2,3-h]pyrrolo[4,3,2-de]quinoline 3 and pyrroloiminoquinones 4 (Shown in Figure 
1.1).  
 
Figure 1.1: General Skeletal structures 
The most abundant motif amongst these is the pyrroloiminoquinone motif 4, of which the 
makaluvamines [such as makaluvamine A (5a)] and isobatzellines [such as isobatzellines C 
(5b)] are structurally the closest. Slight variations and combinations of structure 4 with 
structures 2 and 3 form the basis of compounds such as the damirones 6, batzellines 7, 
makaluvone 8, discorhabdins 9, epinardins 10 and tsitsikammamines 11 (see representative 
examples in Figure 1.2).22,24 Most of these structures are also abundant in the genus Zyzzya, 
family Acarnidae, with makaluvamines A-P being isolated from 2 species in this genus – Z. 
marsailis (from Fiji), Z. fuliginosa –  and therefore not exclusive to just one family.22,25  
Stellenbosch University  https://scholar.sun.ac.za
7 
 
 
Figure 1.2: Representative marine alkaloids 
The makaluvamines were first reported by Ireland and co-workers as novel cytotoxic 
topoisomerase II inhibitors, isolated from the Fijian sponge Zyzzya cf. marsailis.26 These 
compounds have been of great interest due to their remarkable biological activity, with the 
makaluvamines showing antitumour activity against various cancer cell lines.27 The 
biological activity of makaluvamines is not however limited to cancer cell lines, some 
makaluvamines have even been shown to have antiplasmodial activity against Plasmodium 
falciparum. Makaluvamines J (12), G (13) and L (14) showed activities comparable to that of 
chloroquine (15) (Figure 1.3), further highlighting the importance of these molecules.28  
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Figure 1.3: Makaluvamines (12-14) with antiplasmodial activity and chloroquine (15) 
The iminoquinone motif in these structures appear to be of importance, as a study by Carney 
et al. noted that the isobatzellines 5b and discorhabdins 9 exhibited potent cytotoxicity 
against the P388 murine leukaemia cell line, unlike the damirones 6 and batzellines 7, which 
proved inactive. The lack of the iminoquinone motif was cited as a possible reason for the 
lack of activity.29 Barrows and co-workers tested the components extracted from Zyzzya 
fuliginosa (collected from three different locations off the Australian coast) and Zyzzya sp. in 
the NCI 60 cell line human tumour screen.27 The different compounds showed varying levels 
of potency during the screen and correlations were drawn between the potency and 
cytotoxicity as well as unsaturation and substitution on the compounds. The researchers 
noted the difference in activity between compounds such as makaluvamine A (5a) and B 
(16).27 This was also evident in the work of Ireland and co-workers.26 This difference in 
activity will be elaborated on below, when the activity of the different makaluvamines and the 
synthetic analogues are discussed.  
In the initial paper by Ireland and co-workers, the novel makaluvamines were tested against 
the HCT-116 cancer cell line and it was interesting to note that the extra unsaturation in 
makaluvamine B (16) drastically reduced its activity compared to makaluvamine A (5a).26 
Makaluvamine A had an IC50 value of 1.3 M against the HCT-116 cell line, whereas 
makaluvamine B had an IC50 value of more than 50 M. These researchers also tested 
makaluvamines C – F (17-20, Figure 1.4) against the same cell line. Makaluvamines C and 
D (17, 18) were not as effective as makaluvamine A, with IC50 values of 36.2 M and 17.1 
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M respectively. Makaluvamines E (19) and F (20) were very potent though, with values of 
1.2 M and 0.17 M, respectively. The IC50 values of the compounds tested are summarized 
in Table 1.1. 
With makaluvamines D (18) and E (19) there was also a large difference in activity, despite 
only minor structural differences. In the  screen of the NCI’s 60 cell lines by Barrows et al., 
makaluvamine H (21) (Figure 1.4) showed great potency against lung, central nervous 
system, melanoma, ovarian and breast cancer cell lines with IC50 values ranging from 0.15 – 
1.05 g/mL.27 Makaluvamine C (17) (Figure 1.4) showed comparable cytotoxicity to 
makaluvamine H (21), varying against in two areas: it had relatively poor activity against the 
lung cancer cell lines, but showed excellent cytotoxicity against the OVCAR-3 ovarian 
cancer cell line ( IC50: 0.06 g/mL).27  
 
Figure 1.4: Structures of additional makaluvamines 
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Table 1.1: Summary of the antiproliferative activities of makaluvamines A-F against the HCT-
116 cell line 
Makaluvamine 
IC50 against 
HCT-116 (M) 
A (5a) 1.3 
B (16) >50 
C (17) 36.2 
D (18) 17.1 
E (19) 1.2 
F (20) 0.17 
 
Considering the potent anticancer activity shown by these molecules and the variation in 
structure at position 7 [numbering shown on Makaluvamine I (22) in Figure 1.5], various 
synthetic analogues have been prepared and tested for their anticancer activity. A study by 
Shinkre et al. investigated the activities of synthetic benzyl- and phenethyl makaluvamine 
analogues (23a-g and 24a-g in Figure 1.5) against the MCF-7 breast cancer cell line by 
comparing them to the known topoisomerase II targeting, anticancer agents, etoposide (25) 
and amsacrine (m-AMSA) (26).25 
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Figure 1.5: Structure of makaluvamine I (22), synthetic makaluvamine analogues and the 
known topoisomerase II poisons, etoposide (25) and amsacrine (26). 
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When the results of this study and those of an earlier study by the same research group [in 
which a different library of synthetic makaluvamine analogues were produced (27a-e and 
28a-c in Figure 1.5)] were compared to the activity of two naturally occurring makaluvamines 
(17 and 21) and compounds 25 and 26, it was evident that these synthetic analogues had 
similar potency to not only the natural compounds, but also to the two compounds which 
were known to be effective topoisomerase II poisons.25 The IC50 values of these compounds 
against the MCF-7 cell line are given in Table 1.2. 
Table 1.2: Cytotoxicity results of the synthetic makaluvamine analogues and known 
standards against MCF-7 Cell line 
Tested 
Compounds IC50 (M) 
Tested 
Compounds IC50 (M) 
Tested 
Compounds IC50 (M) 
17 2.6 25 35.6 ± 3.4 27a 1.0 ± 0.4 
21 2.3 26 21.7 ± 2.5 27b 1.7 ± 0.5 
23a 2.3 ± 0.8 24a 2.3 ± 0.6 27c 1.6 ± 0.2 
23b 3.6 ± 1.2 24b 3.4 ± 1.1 27d 1.3 ± 0.1 
23c 6.6 ± 0.8 24c 13.7 ± 1.8 27e 1.3 ± 0.3 
23d 34.7 ± 5.9 24d 4.6 ± 0.2 28a 1.8 ± 0.2 
23e 5.2 ± 0.9 24e 2.4 ± 0.4 28b 1.5 ± 0.1 
23f 1.8 ± 0.7 24f 2.8 ± 0.2 28c 1.2 ± 0.03 
23g 2.8 ± 0.3 24g 5.1 ± 0.3   
  
Even when considering the activities of compounds 23d and 24c, the two least active of 
these analogues, compound 23d has similar activity to etoposide (25) and compound 24c 
has a cytotoxic activity comparable to amsacrine (26). It should be noted that etoposide (25) 
and amsacrine (26) have been successfully utilised in the treatment of acute lymphoblastic 
leukaemia in children, therefore proving to be valid chemotherapeutic compounds.30  
The interest in makaluvamines is thus not only due to the excellent in vitro anticancer 
activities against a wide variety of cancer cell lines, but also their mode of action. Etoposide 
(25) and amsacrine (26) are known topoisomerase II poisons and the makaluvamines seem 
to inhibit cell proliferation through a similar mechanism. Interestingly, changes to the main 
scaffold structure seem to affect the mode of action. Some analogues can inhibit both 
topoisomerase I and II, whilst others are more strictly topoisomerase II inhibitors.19 
Compounds such as the 7-lexitropsin-derived makaluvamine (29) and the water-soluble 
synthetic analogues 30a and 30b appear to target both DNA topoisomerases (shown in 
Figure 1.6). The addition of the lexitropsin group in the 7-position seemed to increase the 
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DNA affinity and cellular uptake of compound 29.31 The study by Zhao et al. produced 
different analogues of compound 29 by varying the repeating unit from 1 to 3. By using 
doxorubicin (31), another commercial chemotherapeutic agent (shown in Figure 1.6) as 
standard, their research found compound 29 to have the greatest in vitro cytotoxicity against 
KB, HCT-116, L1210, L1210/Adr, MCF-7 and CHO cancer cell lines.31 The water-soluble 
analogues synthesized by Bénéteau et al. (compounds 30a and 30b) were also reported to 
have excellent antiproliferative activities with IC50 values of 0.3 and 0.38 M, respectively, 
and the compounds were also found to have a nonspecific effect on the L1210 cell cycle.32 
 
Figure 1.6: Lexitropsin-derived and water-soluble makaluvamine analogues and doxorubicin 
In another study, by the Velu group, makaluvamines with substitutions that have different 
characteristics - increased steric bulk, hydrophobicity and hydrophilicity - were synthesized 
over various studies and tested for their anticancer activity.15,19 The activities against three 
cell lines (MCF-7, MDA-MB-468 and HCT-116) all ranged from 0.56 to 11 M.  Interestingly, 
differences in substitution patterns – primarily in the 1-, 5- and 7- positions of the 
makaluvamine scaffold (shown in Figure 1.7, denoted by R1, R2 and R3, respectively) - 
caused the products to show more selectivity for different cell lines. For instance, compound 
27a (Figure 1.5) showed potent activity against the MCF-7 breast cancer cell line with an 
IC50 value of 1.0 M whilst compound 28b (Figure 1.5), which differed in the 7-position by 
having an extra methylene linker, was more effective against the HCT-116 human colon 
tumour cell line with an IC50 value of 0.5 M. The significant difference between the two was 
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that compound 28b has a tosyl-group on the pyrrolo nitrogen and this substitution caused 
the compound to be more effective against a different cell line.19  
The N-tosyl substituted makaluvamines (5-position on the general makaluvamine scaffold) 
do seem to have fairly potent activity profiles, as one of the synthetic analogues (compound 
32, Figure 1.7), synthesized by Nag et al., proved to be highly effective at inducing apoptosis 
and S-phase cell cycle arrest in lung cancer cell lines.19 The compounds caused down-
regulation of MDM2 both dependently and independently of p53. This group also reported 
five novel makaluvamine analogues (33a-e, Figure 1.7) that were very effective against a 
broad spectrum of cancer cell lines. They also noted that breast cancer cells were especially 
sensitive to these novel analogues, most especially towards compound 33b.19  
 
Figure 1.7: Novel makaluvamine analogues produced by Nag et al.19 
 Since these compounds seem to act via different mechanisms of inhibition depending on 
the substitution of the makaluvamine, Nag et al. suggested that they might inhibit cell 
proliferation via a novel mode of action.19  
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1.3 Mechanism of action 
Von Hoff cites the neglect of the importance of the mechanism of action of potential 
anticancer leads as one of the three main reasons a large percentage of promising 
compounds never pass clinical trials.15 This is because greater emphasis is placed on 
whether the compound causes tumour shrinkage (either partial or complete) than on how the 
compound of interest effects the inhibition of cell proliferation. This leads to premature 
clinical trial failure, with many compounds failing even before they reach this point.15 The 
following section will discuss topoisomerase II inhibition, as it is the accepted mechanism of 
action of the makaluvamines, and then consider the possible new mechanisms of action that 
have been suggested. 
1.3.1 Topoisomerase II inhibition 
Ireland and co-workers reported the makaluvamines A-F (Shown in Figure 1.4 in Section 
1.2) to be topoisomerase II inhibitors as the mechanism of action involved cleavage of the 
DNA double-stranded complex. This was confirmed through the use of a decatenation assay 
and a neutral filter assay, in which the makaluvamines were compared to amsacrine (26, 
shown in Figure 1.5). The makaluvamines compared well with amsacrine, with 
makaluvamines A (5a) and F (20) were active at concentration similar to amsacrine.26 
Topoisomerases are enzymes that effect strand breaks in DNA and are critical to the 
survival of all cells. The topoisomerases are classified as either type I or type II, with the type 
indicating whether they effect single-strand DNA breakage (type I) or double-stranded DNA 
breakage (type II).34 As mentioned, the makaluvamines are topoisomerase II inhibitors, 
therefore the discussion will focus mostly on the type II enzyme, as only a few 
makaluvamines (natural and synthetic) had exhibited some form of type I inhibition.19  
The function of the topoisomerase enzymes is to maintain the topology of the DNA double 
helix, which is essential for healthy cell functionality. The topology is disrupted during the 
replication process when the double helix is unwound to open up for RNA transcription. As 
DNA strands are either anchored to membranes or chromosomal scaffolds, the tension due 
to unwinding can cause coils to form in the DNA strand. These coils are referred to as 
supercoils and are classified as either positive or negative coils. Positive supercoils are 
formed on the side the replication is approaching, whereas negative coils are formed behind 
the replication process where the double helix is recombining. This sort of tension can 
translate into knots within the same strand that could have serious implications during further 
replication or other processes. The biggest problems arise during meiosis and mitosis, as 
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these knots can lead to DNA molecules getting entangled to the extent that they cannot be 
resolved. This can lead to cell death.34 To avoid these problems, the topoisomerases 
regulate the topological state of the DNA strands by initiating breaks in the chain and 
releasing the tension. This action eliminates the coils and knots that are formed.35 
Topoisomerase II is present in two isoforms, topoisomerase II and topoisomerase II, 
which differ in mass (the -isoform is 10 kDa smaller than the -isoform) and their activity in 
the removal of supercoils. The -isoform is more efficient at the relaxation of the positive 
supercoils than the negative supercoils, whereas the -isoform does not distinguish between 
the two types of supercoils.34  
The relaxation of these coils happens by the formation of topoisomerase II-DNA cleavage 
complexes which exist in cleavage/religation equilibrium. The cleavage complexes are short-
lived species and generally only account for 0.5-1% of the concentration of the 
topoisomerase II enzyme present in the reaction mixture. This equilibrium is fairly sensitive 
though, as increases or decreases in the concentration of the topoisomerase II-DNA 
cleavage complex could both cause cell death (Figure 1.8). A decrease in the concentration 
leads to the impediment of cellular mitosis, whereas an increase results in apoptosis. It is 
this increase in concentration of the topoisomerase II-DNA cleavage complex that is 
exploited therapeutically by the use of antiproliferative agents. Topoisomerase II poisons act 
by stabilizing the cleavage complex and thus increases the concentration of these 
complexes within the DNA scission mixture. This prevents DNA replication, while promoting 
apoptosis.34 It is interesting to note that makaluvamine A produced strand scission factor 
comparable to that of amsacrine.26 
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Figure 1.8: Simplified version the topoisomerase II-DNA cleavage complex formation by 
Deweese and Osherhoff34 
Along with being known as topoisomerase II inhibitors, the makaluvamines have also been 
found to be DNA intercalators, attributed to its charged, planar structure. The 
makaluvamines continue to be seen and analysed as topoisomerase II inhibitors, but there 
have been research groups that have postulated that these compounds might inhibit cellular 
proliferation by different or novel modes of action. Danieli and co-workers also reported 
observing DNA fragmentation in HeLa cells treated with three makaluvamines.36  
1.3.2 Novel mechanisms 
Along with topoisomerase II inhibition and the other pathways by which apoptosis is induced, 
there have been probes into possible new mechanisms by which cell death is promoted. 
Zhang and co-workers reported on various new possible mechanisms, based on trials on a 
fluorobenzyl analogue of the makaluvamines (33b).19 The new mechanisms (dashed lines) 
along with the established mechanisms (solid lines) are shown in Figure 1.9. 
One mechanism proposed by Zhang and co-workers is the activation of p53 through the 
down-regulation of MDM2. This p53 activation stimulates apoptosis and cell cycle arrest. 
This was confirmed in in vitro and in vivo models, both showing an increase in p53/p-53 
expression levels and decreased expression levels of MDM2. Another proposed mechanism 
relates to the levels of reactive oxygen species (ROS) in the cell. ROS levels were noted to 
be heightened as treatment with the makaluvamines resulted in the decrease of 
mitochondrial membrane potential and thereby leading to mitochondrial collapse, followed by 
Stellenbosch University  https://scholar.sun.ac.za
18 
 
cell death. This is an especially useful pathway to target, as the heightened metabolisms of 
cancer cells lead to increased production of ROS. This is attributed to the tumorigenic 
properties of ROS as it leads to an increase cell proliferation. It also heightens the survival 
rate of these cells and aids in cellular migration. The cell proliferation of ROS is due to its 
ability to initiate tumour growth. Due to this, cancer cells have heightened levels of 
antioxidant pathways to successfully deal with the increased concentrations of ROS. These 
pathways include the up-regulated mechanisms of glutathione, superoxide dismutase and 
catalase, leading to hyposensitivity towards ROS.37 The inhibition or down-regulation of 
these pathways have been shown to be effective in the selective killing of tumour cells, as 
the cancer cells are terminated by the ROS.38  
These researchers also investigated the activation of the phosphatidylinositol 3′-kinase 
(PI3K) and the PI3K-Akt pathway.19 The activation of PI3K in cancer cells is generally 
triggered by an over-expression of the fatty acid synthase (FAS), an enzyme that forms part 
of the metabolism of fatty acids to cater to the cancer cells increased energy demands.39 
The fluorobenzyl makaluvamine analogue (33b) was found to down-regulate the activation of 
PI3K and thereby affected a decrease in the production of phosphorylated Akt (p-Akt). This 
down-regulation caused a suppression of the PI3K-Akt pathway and along with the down-
regulation of MDM2, proved to be a different mode of inhibition to what has previously 
reported for this class of compounds. It was also postulated, that the makaluvamines might 
affect the expression of FAS, but this was not verified experimentally.19 
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Figure 1.9: Established and possible new mechanisms suggested by Zhang and co-workers. 
(Adapted from the diagram published by Zhang and co-workers)19 
Based on the report by Zhang and co-workers, it is therefore clear that more probes into the 
mechanism of action of the makaluvamines are necessary.19 Therefore the aim of this study 
is also to produce analogues of the makaluvamines that can be tested not only for their 
antiproliferative activity, but also for their mechanism of action. This could serve to add to the 
literature on these compounds and improve their standing as promising clinical agents. 
Some of the compounds synthesized by Zhang and co-workers [the benzylamine- (33a) and 
fluorobenzyl analogues (33b)] have already been identified as potential clinical leads.19 
In the following section, various synthetic strategies will be discussed. The strategies start 
with the first reports after the discovery of the makaluvamines and subsequent increases in 
the efficacy of the synthesis or shortening thereof. Shortcomings of the various strategies will 
be highlighted, ultimately providing a rationale for the choice of the strategy by Joule and co-
workers as the basis for this study.40  
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1.4 Synthetic Approaches 
Since their discovery in 1993, the makaluvamines have received attention for their potent 
anticancer activity.26 The initial report by Ireland and co-workers showed that these 
compounds were especially potent against the HCT-116 colon cancer cell line. 
Makaluvamines A, E and F (5a, 19, 20 in Figure 1.4) were very potent with IC50 values of 1.3 
M, 1.2 M and 0.17 M, respectively.26 Makaluvamine G (13, Figure 1.4) was reported in 
the same year by Carney and Scheuer and also exhibited moderate cytotoxicity against the 
P388, MCF-7, A549, HT-29 and KB cancer cell lines.29 They also reported moderate 
immunomodulatory activity and also noted that compound 13 was not toxic towards mice in 
in vivo testing, even at the highest tested dose of 210 mg/kg.29 This is especially promising 
in terms of treatment possibilities, as it could possibly inhibit tumour growth without 
adversely affecting healthy cell function.  
In the light of these promising results, the interest turned to the synthesis of these 
compounds. The first reported synthesis came from Yamamura and co-workers.41 This was 
a fairly short synthetic strategy, but did rely on the availability of a fairly complex starting 
reagent. Their synthesis started with the lactamization of a tetra- or pentasubstituted indole 
34 (Scheme 1.1), followed by a reduction and an oxidation to deliver the 7-methoxy 
pyrroloiminoquinone 35. This compound could then be converted into the desired 
makaluvamine analogue by reacting it with an appropriate amine [the use of ammonia 
solution is shown in Scheme 1.1 to produce makaluvamine A (5a)]. Therefore, the following 
discussion of synthetic strategies will investigate the construction of the 7-methoxy 
pyrroloiminoquinone scaffold, as it allowed for the generation of a diverse library from this 
central precursor. It should be noted that the various strategies do have different substitution 
patterns in the 1- and 5-positions (shown on the general makaluvamine scaffold in Figure 
1.7), such as methyl groups and tosyl-groups.  
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Scheme 1.1: Synthesis by Yamamura and co-workers.41 i) 10 M KOH, MeOH; ii) DCC, THF; 
iii) BH3.SMe2, THF; iv) CAN, 60% aq. CH3CN; v) NH4OH, MeOH/CHCl3; vi) TFA, MeOH 
The main drawback to the strategy by Yamamura and co-workers was the reliance on a 
fairly complicated starting material, a compound which had to be synthesized as well. 
Yamamura and co-workers initially reported the synthesis of makaluvamines A to D,41 but 
later updated their strategy to include makaluvamine E as well.42  
White et al. reported some synthetic studies where they explored synthetic routes starting 
with veratraldehyde (36, Scheme 1.2) and 2,3-methoxybenzoic acid (37, Scheme 1.3)43 – 
much simpler starting materials than used by Yamamura and co-workers. The first strategy 
(from Scheme 1.2) started from veratraldehyde (36), unfortunately they encountered 
significant problems with this strategy in the final steps to construct the desired 7-methoxy 
pyrroloiminoquinone (35). The synthesis started with a Knoevenagel condensation to form 
the ester (38), followed by a hydrocyanation/decarboxylation to give product 39. Successive 
hydrogenation and acetylation reactions then gave products 40 and 41. This was followed by 
an oxidation and cyclization with hypervalent iodine to furnish the iminoacetal (42). Another 
hydrogenation step produced the tetrahydroquinoline (43) and treatment of this product with 
cerium ammonium nitrate produced the iminoquinone (44a). From here on, significant issues 
arose with construction of the pyrrole ring (44b) and the researchers thus decided to 
abandon this route. This unsuccessful route is reported here, as the strategy differed from 
the strategy reported by Yamamura and co-workers in that it started from a much simpler 
starting material and attempted the construction of a tetrahydroquinoline basis (43), before 
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arriving at an iminoquinone structure (44a). This compound (44a) was also reported to be 
fairly unstable.43 As the coupling of the exo-cyclic nitrogen to the “ortho-position” of the 
iminoquinone to produce compound 44b proved inefficient, it also serves to highlight that 
even early on, researchers were posed with difficult synthetic challenges.  
Scheme 1.2: First synthetic strategy by White et al.43 i) NCCH2CO2Et, piperidine, toluene, 
110 oC; ii) NaCN, CHCl3, EtOH, H2O,  iii) H2, Pd/C, Ac2O; iv) H2, Pd/C, MeOH, HCl; v) NH3, 
CHCl3 vi) PhI(OAc)2, CF3CH2OH; vii) H2, Pd/C, MeOH; viii) CAN, MeCN (Yields for steps i 
and ii are not given). 
Whilst the first route focused on the initial construction of a tetrahydroquinoline structure, in 
the second route White et al. focused on the initial construction of an indole backbone. The 
synthetic route started with 2,3-dimethoxybenzoic acid (37, Scheme 1.3) and was converted 
into the carbamate 45 via a Curtius rearrangement. The carbamate was next converted into 
the aniline (46) and subsequently into the phenyl hydrazine (47). This compound was next 
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treated with 2,3-dihydrofuran in hydrochloric acid to give a mixture of compounds 48 and 49 
in a 1:1 ratio. The mixture was subsequently converted into indole 50 by means of a Fischer 
indolization, along with the formation of indole 51 as a side product via an ipso-substitution 
of the ortho-methoxy group. This side product proved to be difficult to remove and the 
mixture was used without purification for the subsequent protection step, which included the 
tosylation of the hydroxyl group as well as the indole nitrogen. The compounds were then 
readily separated and nitrated to produce compounds 52a and 52b in a 1:1 mixture.  
This is problematic for this synthetic route, as half of the material is lost in this separation by 
forming the undesired isomer. The isomers were easily separated by means of column 
chromatography. Reduction of the 4-nitro derivative (52a) using Adams’ catalyst then gave 
compound 53. The air-sensitivity of compound 53 prompted the immediate treatment of this 
compound with N,N-diisopropylethylamine to produce compound 54 in a very good yield of 
85% over the two steps. This product was oxidized to produce the iminoquinone 55, which 
was then converted into its tosylate salt, compound 56. White et al. thus managed to 
synthesize the 7-methoxy pyrroloiminoquinone (56) in 13 steps. The synthetic strategy was 
fairly efficient in the early stages (compound 47 was synthesized in 64% yield over 5 steps), 
but the yields were very poor after this step. This was due to the formation of inseparable 
mixtures and unstable products, which meant yields could not be accurately reported. These 
researchers also noted that for a successful substitution at C-7 by a desired amine, the 
imino-nitrogen should be protonated (Shown in Section 3.2, Scheme 3.6).43 
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Scheme 1.3: Successful makaluvamine core synthesis by White et al.43 i) (PhO)2PON3, 
EtOH, Et3N; ii) KOH, EtOH; iii) NaNO2, HCl; iv) SnCl2, HCl; v) NaOH; vi) 2,3-dihydrofuran, 
HCl; vii) ZnCl2,Ethylene glycol; viii) p-TsCl, NaH, THF; ix) AcONO2, Ac2O; x) H2, PtO2, EtOH; 
xi) (i-Pr)2NEt; xii) CAN, MeCN, H2O; xiii) p-TsOH 
Stellenbosch University  https://scholar.sun.ac.za
25 
 
A significant drawback to this synthesis arose after the construction of the hydrazine (47). 
The treatment of compound 47 with 2,3-dihydrofuran in acidic medium gave a mixture of 
compounds (48 and 49), which the authors mention do not detract from the synthesis as this 
mixture still gave compound 50. This was not exclusive though, as the researchers reported 
the ipso-substitution to also give compound 51 as a side product. The mixture of compounds 
50 and 51 was isolated in a poor yield of 32%. What makes this even less desirable, is that 
the ratio of the desired product to the undesired product was 1:7. The subsequent step also 
gave rise to an almost 1:1 ratio of the 4-nitro-substituted indole (52a) and 2-nitro-substituted 
indole (52b). Therefore, this route was also not considered. 
It should be noted that the successful use of an indole to construct the makaluvamine 
backbone was also achieved by Sadanandan et al., when they reported the use of a 
trimethoxyindole to synthesize the tricyclic pyrroloiminoquinone backbone.33 Their strategy 
involved starting off by the conversion of 2,4,5-trimethoxybenzaldehyde (57, Scheme 1.4) 
into the corresponding azidocinnamate (58) via a Knoevenagel condensation. The 
researchers utilized the Hemetsberger indolization to convert compound 58 into the indole-2-
carboxylic ester (59). After a saponification and decarboxylation reactions, 4,6,7-
trimethoxyindole (60) was isolated in 73% yield. This indole was then converted into the N-
BOC-3-ethylaminoindole (61) over 5 steps. This compound was then oxidised to furnish the 
pyrroloquinone (62) and the protecting group was removed by treatment with trifluoroacetic 
acid. This produced the ammonium salt (63) which when dissolved and stirred in chloroform, 
underwent the ring closure to give the desired 7-methoxy pyrroloiminoquinone (64).  
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Scheme 1.4: Makaluvamine synthesis by Sadanandan et al.33 i) N3CH2COOMe, 
NaOMe/MeOH ii) Xylene,  iii) NaOH iv) HCl v) Ba(OH)2,  vi) CAN, n-Bu4NHSO4, DCM vii) 
TFA, DCM viii) CHCl3 
The synthesis by Sadanandan et al. was fairly successful, as compound 62 was synthesized 
in an overall yield of 28% and a quantitative conversion to compound 64. The construction of 
the 3-ethylamino-indole (61a) following the synthesis of compound 60 involves two reduction 
steps separated by the tosyl-protection of the indole nitrogen, the second of which is a fairly 
strong fire hazard, if a nitrogen atmosphere is not maintained. The long reaction time for this 
reaction means constant monitoring would be necessary. The precursor to compound 61a, 
the N,N-dibenzylindole (61b) was reduced using palladium black and ammonium formate in 
absolute ethanol and immediately protected with BOC anhydride, due to the sensitivity of the 
free amine (Scheme 1.5). The reduction using palladium black was the step reported as a 
fire hazard) 
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Scheme 1.5: Reduction and successive protection to afford compound 61a.33 i) Pd black, 
Ammonium formate, EtOH, HCOOH; ii) (BOC)2O, Et3N, DMAP, CH2Cl  
Peat and Buchwald reported the synthesis of an indole intermediate (65, Scheme 1.6), and 
applied this compound to the synthesis of various makaluvamines and damirones, using 
zirconocene and palladium catalysts for the formation of the tetrahydroquinoline and pyrrole 
rings respectively (Shown in Scheme 1.6).44 This synthesis started with the bromination of 
3,4-dimethoxyaniline (66) to produce compound 67. This compound was treated with 4-
bromobut-1-ene to give product 68 and subsequent methylation introduced the methyl group 
that is characteristic of makaluvamines C and G (17 and 13, Figure 1.4) to give compound 
69. The tetrahydroquinoline structure was then formed using a zirconocene catalyst, 
followed by iodination and substitution with benzylamine to produce compound 70. The 
pyrrole ring was then formed by palladium-catalysed ring closing reaction to produce 
compound 71, which subsequently underwent aromatization to transform from the 
dihydropyrrole to the pyrrolo-moiety with the removal of the benzyl group under reductive 
conditions to finally generate the indole 65. According to the authors, oxidation of these 
structures to afford the 7-methoxy pyrroloiminoquinone (72) precursors have been reported 
(no references were given in the paper) as part of the total synthesis of makaluvamine C 
(17). Investigation into this did not deliver results specific to makaluvamine C, but 
considering that these pyrroloiminoquinone moieties are generally furnished by treatment 
with cerium ammonium nitrate. Peat and Buchwald thus provided a short and efficient 
synthesis of these makaluvamine precursors, but still with a reliance on transition metals for 
the ring closing steps. 
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Scheme 1.6: Synthetic route by Peat and Buchwald.44 i) Bu4NBr3, MeOH, DCM; ii) 4-
bromobut-1-ene, K2CO3, NaI; iii) MeI, K2CO3; iv) Cp2Zr(Me)Cl, t-BuLi, THF; v) I2, DCM; vi) 
BnNH2, THF; vii) 2.5 mol% Pd2(dba)3, P(o-tolyl)3, NaOtBu, toluene; viii) 10 mol% Pd/C, 
HCO2NH4, MeOH 
In comparison, Joule and co-workers reported an even shorter synthesis with a slightly lower 
dependence on some of the heavier and more expensive metals reported in syntheses up to 
this point, with the exception of NiCl2.45 The toxicity of nickel and the nickel borides that form 
during the reduction are highly toxic, but can be safely worked with and disposed of. Thus, 
the method of Joule and co-workers is more cost-effective in terms metal catalysts used. 
The reported synthesis started off with the chlorination of the 8-position of 6,7-dimethoxy-4-
methyl-5-nitroquinoline, previously synthesized in two steps (73, Scheme 1.7), with N-
chlorosuccinimide to afford the penta-substituted quinoline 74. Oxidation of this compound 
by means of Vismara’s procedure selectively gave the aldehyde 75, which was then 
converted into the acetal (76). This product was then reduced using NaBH4 and NiCl2.6H2O, 
which reduced both the nitro group and the quinoline to a tetrahydroquinoline, to furnish the 
diamine (77). It is at this point in the synthetic strategy that something fairly interesting 
happened. The diamine was treated with aqueous 1N HCl in tetrahydrofuran in hopes of 
deprotecting the acetal and forming the pyrrole ring. However, instead of the expected 
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product, the 7-methoxy pyrroloiminoquinone (78) was isolated. The researchers speculated 
that the acidic medium had catalysed the elimination of the chlorine and thus, formed the 
iminoquinone. This shortened the synthesis and avoided the need for an oxidation step 
using cerium ammonium nitrate to produce compound 78. Although this synthetic route is 
very short, it makes the derivatization of the 5-position (shown on compound 78 in Scheme 
1.7) on the pyrroloiminoquinone a bit more problematic. A distinct advantage of the route 
reported by Peat and Buchwald (as described earlier) was that this position could be easily 
derivatized. 
 
Scheme 1.7: Synthetic route reported by Joule and co-workers45 i) NCS, DMF, 60 oC; ii) I2, t-
BuI, FeCl2, TFA, DMSO, 80 oC; iii) MeOH, HCl, reflux; iv) NaBH4, NiCl2, MeOH, 0 oC; v) aq. 
1N HCl, THF, 40 oC 
It should be noted that, Kita et al. also managed to synthesize compound 78 in 6 steps by 
starting with 6,7-dimethoxyindole (79, Scheme 1.8).46 This compound was converted into the 
3-ethylazido indole (80) over 5 steps following the established procedure reported by 
Sadanandan et al., for the derivatization of the 3-position.33 Instead of the amino-substituted 
indole though, Kita et al. synthesized the azido derivative. Compound 80 was successfully 
converted into the pyrroloiminoquinone (78) in one step through the use of a hypervalent 
iodine compound – phenyliodine (III) bis(trifluoroacetate) (PIFA).  
Stellenbosch University  https://scholar.sun.ac.za
30 
 
 
Scheme 1.8: Synthesis by Kita et al.46 i) PIFA, Me3SiOTf 
The shortcoming of this synthesis was that a search on the commercial availability of the 
starting material, compound 79, delivered no results. It meant that this compound would 
have to be synthesized as well. Corey and co-workers reported a synthesis of 6,7-
dimethoxyindole (79) in 6 steps, thus this synthetic route would be significantly longer.47 
After considering all these design strategies, it was decided to follow a synthetic route based 
on a variation of the quinoline synthesis reported by Joule and co-workers that formed part 
of a formal synthesis of batzellines, isobatzellines, discorhabdins and makaluvamine D.45 
Joule and co-workers later expanded on this work and published a second paper on the 
formal syntheses of these compounds, using 6,7-dimethoxy-4-methylquinoline (81, shown in 
Scheme 2.1 in Section 2.1) as starting point.40 The reason for selecting this route above the 
other possible routes was that it offered one of the shorter routes to the pyrroloiminoquinone 
precursor (72) with the option of introducing a methyl group. The strategies reported by 
White et al. (Scheme 1.3) served to show what was inefficient, as their synthetic strategy ran 
into considerable issues towards the end.43 The synthesis by Sadanandan et al. was fairly 
efficient, with good to excellent yields, but only produce the pyrroloiminoquinone precursor in 
13 steps. While it does have scope for the introduction of a methyl group, this would have 
increased the length of the synthesis.33 The procedure by Peat and Buchwald, would 
perhaps be the second best candidate, but it was not considered due to its reliance on more 
expensive metal catalysts for ring-closing reactions.44 Similarly, the synthesis by Kita et al. 
was not considered, due to the need for PIFA in the final step as well as not having scope for 
the introduction of the methyl group. 
Stellenbosch University  https://scholar.sun.ac.za
31 
 
Therefore the synthetic strategy reported by Joule and co-workers was selected as the 
template for constructing the 7-methoxy pyrroloiminoquinone (72), which would serve as 
precursor to the makaluvamine analogues of interest.40  This strategy will be discussed more 
in depth in the next section, along with the methods investigated for the optimization of 
certain steps (or possible alternatives in certain instances) and the mechanisms or proposed 
mechanisms where available.   
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Chapter 2 
2.1 Synthetic aims 
As mentioned at the end of Section 1.4, it was decided that the second paper on the formal 
syntheses of batzellines, isobatzellines, discorhabdins and makaluvamines by Joule and co-
workers was to serve as the template for this project. The strategy (Scheme 2.1) involved 
using the quinoline backbone and constructing the quinoline from 3,4-dimethoxyaniline (66) 
and methyl vinyl ketone (MVK) (82), as reported by Joule and co-workers in a different study 
of the structurally related damirones.48 This quinoline would then be nitrated to give 
compound 73, which would subsequently be oxidised to give compound 83. The aldehyde 
would then be protected to afford acetal 84 and this product eventually reduced to give the 
diamine 85. At this point, we would augment the synthetic strategy by selectively introducing 
a methyl group to the anilino-nitrogen to produce compound 87. This compound would then 
be oxidised using cerium ammonium nitrate to give the 7-methoxy scaffold (72), a single 
step away from the desired makaluvamines. The aim was then to synthesize the 
benzylamine (88), aniline (89) and phenyllhydrazine (90) substituted makaluvamine-
derivatives. These compounds strongly resemble makaluvamine G (13), shown earlier in 
Figure 1.4.  
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Scheme 2.1: Planned synthetic strategy based on work reported by Joule and co-workers40 
i) FeCl3.6H2O, glacial AcOH 140 oC; ii) Fuming HNO3, < -40 oC; iii) I2, t-BuI, FeCl2, TFA, 
DMSO, 80 oC; iv) MeOH, HCl, reflux; v) NaBH4, NiCl2, MeOH, 0 oC; vi) aq. 1N HCl, THF, 40 
oC; vii) Desired amine, MeOH 
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2.2 Synthesis 
In this section, the synthetic studies and the methods of optimization will be discussed. The 
experimental data pertaining to each section is described in detail in Section 4.2 of Chapter 
4. Unsuccessful and duplicate reaction entries are available in an appendix. 
2.2.1 Synthesis of the quinoline backbone (81) 
The synthetic strategy was commenced by the synthesis of the quinoline backbone. The 
starting material was 3,4-dimethoxyaniline (66), which was treated with methyl vinyl ketone 
[MVK (82)] and iron(III) chloride hexahydrate in glacial acetic acid (Scheme 2.2). The 
dimethoxyaniline (66) was first dissolved in glacial acetic acid and the iron(III) chloride 
hexahydrate was added portion-wise as the mixture was heated to 60 oC. The MVK (82) was 
then added slowly over 30 minutes. After the addition of the MVK, the temperature of the 
reaction was raised. The first time, the reaction was monitored by TLC at different 
temperatures. The temperature was first raised to 120 oC and after 30 minutes, no change 
occurred. The temperature was then raised to 130 oC and after another thirty minutes, some 
change in terms of TLC spot formation started to occur. The temperature was then finally 
raised to 140 oC and the reaction was left to stir for 130 minutes, after which all of the 
starting material had been consumed. Upon cooling of the reaction mixture to room 
temperature, a solid precipitate crashed out of the solution.  
 
Scheme 2.2: Formation of the quinoline backbone. i) Methyl vinyl ketone (82), FeCl3·6H2O, 
Glacial acetic acid, 140 oC, 2h. 
The solid product was collected and the prescribed work-up was followed. Initially, 3.2 g of 
solid product was collected – which was surmised to be the wet acetate salt of the quinoline 
– and this was added to a sodium hydroxide solution (50% w/v). A very thick moss-green 
suspension formed and this was extracted with ethyl acetate, unfortunately giving rise to a 
very thick emulsion. Further extraction, drying and evaporation only resulted in the isolation 
of the desired product in 18% yield. This was confirmed by 1H Nuclear Magnetic Resonance 
(NMR) spectroscopy, with the spectrum showing the singlet corresponding to the two 
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methoxy-groups of the starting material (surprisingly at the same ppm), along with a newly 
formed singlet that corresponded to the methyl group in the 4 position of the quinoline. The 
protons in the aromatic region also confirmed that it was indeed the product when compared 
to the chemical shifts reported in the literature.40 
 
Spectrum 2.1: 1H NMR spectrum of the methylquinoline 81 
This was a very poor yield and did not compare well to the reported literature yield of 66%.48 
Possible reasons for this were considered – with the work-up regarded as one of the main 
problems, as the formation of the emulsion could hinder efficient extraction of the product. 
Therefore, rather than using an excess of the sodium hydroxide solution, it was decided to 
basify the product in a drop-wise manner, as well as to change the solvent used for 
extraction, as ethyl acetate had a propensity for forming emulsions under the conditions 
utilized.  
The reaction was then repeated and upon completion (confirmed by the disappearance of 
the starting material spot on TLC), the reaction mixture was cooled on ice for 30 minutes. 
The solid that formed was collected by means of vacuum filtration and then dissolved in 40 
mL of distilled water. This mixture was then basified to a pH of 11 by the addition of a 50% 
w/v sodium hydroxide solution in a drop-wise manner and rigorously extracted with 
dichloromethane (CH2Cl2). The product was isolated in a marginally improved yield of 30%. 
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The strong basic work-up still seemed to be a problem, so it was decided to attempt the 
following nitration step on the acetate salt (91) of the quinoline (Scheme 2.3) to avoid the 
unnecessary loss of product. In a repeated experiment, after all of compound 66 had been 
consumed, the acetate salt (91) was collected and dried under high vacuum. Corresponding 
to a yield of 73% for the salt, this material was slowly added in portions to fuming nitric acid 
at -45 oC. The addition was done over an hour, whilst maintaining the temperature between  
-50 oC and -40 oC and then left for another hour to stir, with the temperature still below -40 
oC. The reaction mixture was then poured over ice and basified to pH 12 using a 50% w/v 
sodium hydroxide solution, followed by a rigorous extraction with CH2Cl2. Unfortunately, with 
this method, the product was isolated in a yield of only 12% over the two steps.  
 
Scheme 2.3: Quinoline formation and successive nitration. i) Methyl vinyl ketone (82), 
FeCl3·6H2O, Glacial acetic acid, 140 oC, 2 h; ii) Fuming HNO3, < -40 oC, 2 h. 
Since the strong basic work-up has proved unsuccessful, it was decided to use a milder 
base in the work-up procedure. So instead of using the 50% w/v sodium hydroxide solution, 
the salt was added to CH2Cl2 to form a slurry, after which a 10% w/v K2CO3 solution was 
added whilst stirring. This time, after the work-up of the reaction, the product was isolated in 
a yield corresponding to 36%. The use of a milder base appeared to have a beneficial effect 
on the work-up, as the yield was doubled from the first attempt where 50% w/v sodium 
hydroxide solution had been used. Finally, it was decided to use a more concentrated basic 
work-up. 
In the next attempt, after the completion of the reaction, the acetate salt (91, Scheme 2.3) 
was isolated again and dried. A portion of the product was then used to try a different work-
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up. Instead of 10% w/v K2CO3 solution, a saturated solution of sodium bicarbonate was 
used. Portions of the salt were then slowly added to a stirring solution of saturated sodium 
bicarbonate. Upon addition, there was an evolution of gas from the reaction mixture and 
ethyl acetate was added. Subsequently, this was concentrated under reduced pressure and 
dried under high vacuum to finally give the desired product in a yield of 62%, which was 
much closer to the 66% reported in literature. The results for all the attempts are 
summarized in Table 2.1 below: 
Table 2.1: Optimization conditions and yields 
 Work-up Base 
Amount used (per mass 
of acetate salts) 
Extraction 
Solvent 
Yield 
(%) 
1 50% w/v NaOH solution 100 mL per 3.2 g Ethyl Acetate 18 
2 50% w/v NaOH solution Dropwise on 1.04 g (pH 11) Dichloromethane 30 
3 10% w/v K2CO3 solution 150 mL per 1.73 g Dichloromethane 36 
4 Saturated NaHCO3 solution 100 ml per 2.4 g Ethyl Acetate 62 
 
The mechanism of this reaction was also considered and a possible mechanism is 
suggested in Scheme 2.4. The mechanism is postulated to start with the protonation of the 
methyl vinyl ketone (82) by the acidic solvent, thereby increasing the electrophilicity of the 
compound. The mechanism that follows then resembles the Skraup synthesis of quinolines 
where the aniline (66) attacks at the Michael-acceptor to give intermediate 92a, which 
through a loss of a proton and tautomerization, forms compound 92b.49 The protonation of 
compound 92b to form compound 92c, sets it up for an intramolecular nucleophilic attack 
resulting in the formation of intermediate 93a. A loss of a proton and rearomatization 
produces the 1,2-dihydroquinoline (93b). Then, whereas the Skraup quinoline synthesis 
uses nitrobenzene as oxidant, FeCl3.6H2O acts as oxidant in this synthesis to give product 
81.  
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Scheme 2.4: Proposed mechanism of the quinoline formation. 
When the synthesis was repeated at a later stage to remake some starting material, the 
work-up procedure was modified slightly to see if the filtration of the acetate salt could 
potentially be a point in the synthesis where more product could be isolated. Therefore, 
instead of filtering off the salt after cooling the reaction mixture on ice, the acetic acid was 
removed in vacuo to give a brown precipitate. The work-up was then continued as usual and 
the product was isolated in a very good yield of 84%, greatly improving upon the yields of 
previous attempts, as well as what was reported in the literature. 
In summary, the use of a strong basic work-up proved to be detrimental to the success of the 
reaction, as the continued struggle with emulsions in the early stages along with the use of 
ethyl acetate meant that the extractions were very inefficient. The exact cause of this was 
never determined, but the increases in yields observed when a milder basic work-up was 
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used did seem to support this logic. The removal of acetic acid in vacuo also proved to be 
very successful, as the yields increased remarkably. This change was made due to a 
suspicion that the glacial acetic acid used for this step had become wet and rather than distil 
this first, the decision was made to first see what effect in vacuo removal would have 
compared to filtration. The success of this change in the procedure suggested that some 
product might have been lost during the filtration step.  Thus, by increasing the yield to this 
extent, the synthetic strategy started off more efficiently. 
2.2.2 Selective nitration of the quinoline (82) 
The next step of the synthesis involved the selective nitration of the 5-position of the 
quinoline scaffold (81, Scheme 2.5). The procedure prescribed by Joule and co-workers 
used fuming nitric acid (nitric acid with a concentration greater than 99.5%), and it was 
decided to follow this strategy.40 The strategy involved nitration at temperatures below -30 
oC, otherwise there is a possibility of undergoing nitration in both the 5- and 8-positions to 
form compound 94.  
 
Scheme 2.5: Nitration of the quinoline. i) Fuming HNO3, < -40 oC, 2 h. 
The reaction was started by cooling fuming nitric acid to -50 oC in a dry ice and acetone 
mixture bath under a flow of nitrogen. The first portion of compound 81 was added and it 
turned out that the nitric acid had frozen. Fuming nitric acid has a melting point of -42 oC, so 
the reaction mixture was left to warm slightly to -40 oC and the addition was continued. Care 
was taken to maintain the temperature at about -40 oC during the addition of the quinoline, 
which was added over an hour. The temperature was monitored using a thermometer that 
was calibrated for use at temperatures below 0 oC. The reaction was left to stir for another 
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hour before the reaction was quenched by pouring the reaction mixture over an ice slurry 
and then basifying to a pH of 12 with 50% w/v sodium hydroxide solution. After the work-up, 
the product was isolated in a disappointing yield of 28%. The product was confirmed to be 
the desired product by means of 1H NMR spectroscopy, in which the disappearance of one 
of the aromatic protons was noted. The singlet of the proton in the 5-position of the quinoline 
was no longer visible and the addition of the nitro-group also led to the resolution of the 
singlet that corresponded to the two methoxy groups. These two groups now appeared as 
two singlets that were very close to each other. All of the chemical shifts also correlated well 
to the literature values.40 
 
Spectrum 2.2: 1H NMR spectrum of the nitration product (73) 
Unfortunately, the yield was substantially lower than the reported literature yield of 63% and 
this was attributed to the freezing of the fuming nitric acid. The reaction was then repeated 
with the only difference being that the dry ice and acetone ice bath was maintained at -40 
oC. This time, after extraction, the product was isolated in 56% yield, thus doubling the 
previous yield. This reaction was done repeatedly throughout the duration of the project, with 
only slight changes to the work-up and with this, the yield was increased to 79%, which 
improved on the literature yield of 63%. The significant change was only in the rate of 
addition of the sodium hydroxide solution to quench the acid upon completion of the 
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reaction. In one instance, the sodium hydroxide solution was accidentally added a bit too 
fast, causing the mixture to heat up whilst still being acidic (pH of the mixture was monitored 
by universal indicator paper). This caused concern that the compound might have 
undergone nitration in the 8-position, to form compound 94 as a side product. Fortunately, 
no side product formed and only compound 73 was isolated in an improved 79% yield, as 
the 1H NMR spectrum showed the singlet corresponding to the 8-position of the quinoline. 
2.2.3 Oxidation of the aromatic methyl group of compound 73 to 
give product 83 
After the successful nitration, the quinoline (73) needed to be oxidized to the substituted 
quinoline-4-carbaldehyde (83). Generally, aromatic methyl groups can easily be oxidised to 
carboxylic acids by various means, but selectively oxidizing to the corresponding aldehyde 
has proved to be more difficult. Strategies would, therefore, involve over-oxidizing to the 
carboxylic acid, followed by a reduction to the alcohol and successive oxidation to the 
aldehyde by means of the Swern oxidation or by using MnO2. Joule and co-workers made 
use of a very efficient oxidation initially reported by Vismara et al., which successfully and 
selectively converted heteroaromatic methyl groups to their corresponding aldehydes in high 
yields.50 Their study involved the conversion of lepidine (95) to quinoline-4-carbaldehyde 
(96) using a new procedure involving the use of iodine, tert-butyl iodide, trifluoroacetic acid 
(TFA), iron(II) chloride tetrahydrate and dimethyl sulfoxide (DMSO) acting as both solvent 
and oxidant. In spite of the success of the procedure, there have been no investigations into 
the mechanism of this oxidation, as far as a literature search was concerned. Vismara and 
co-workers also speculated as to the mechanism and did investigate the importance of each 
of the components, although they did not go as far as to suggest a full mechanism. The 
formal stoichiometry was suggested to be as it is in Scheme 2.6, but this does not take into 
account the role of the tert-butyl iodide. The formation of dimethyl sulfide as a by-product, 
does suggest some similarity to the Swern oxidation.  
 
Scheme 2.6: Stoichiometry of the oxidation. i) I2, DMSO. 
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When the reaction was performed without tert-butyl iodide, a yield of only 13% was achieved 
compared to the quantitative yield when it is used. This highlighted the importance of the 
tert-butyl iodide and the stoichiometry was reconsidered (shown in Scheme 2.7). Vismara 
and co-workers therefore suggested that the major oxidant must be the oxyalkylsulfonium 
iodide (97), formed by the reaction of DMSO and tert-butyl iodide.  
 
Scheme 2.7: Revised stoichiometry of the oxidation 
The stoichiometry also suggests that one equivalent of tert-butyl iodide is regenerated during 
the oxidation. The reaction also seems strongly dependent on the acid catalyst, as its 
absence also lowers the yield to 10–12%. It was, therefore, suggested that the acidic 
medium could cause the formation of the dienamine (98, Scheme 2.8) – even if only in small 
amounts at equilibrium – which could be very reactive towards the oxyalkylsulfonium iodide 
species (97).  
 
Scheme 2.8: Equilibrium under acidic conditions 
The importance of the ferrous chloride tetrahydrate and iodine were also investigated, as 
their absence produced yields of 60 ̶ 64% and 15%, respectively. All four components were, 
therefore, essential for the success of this reaction. Due to the efficacy of this reaction, Joule 
and co-workers, therefore, successfully utilized it in their work. They reported synthesizing 
compound 83 (Scheme 2.9), in a 73% yield. This reaction was repeated exactly as 
prescribed in our synthesis. The starting material, 6,7-dimethoxy-4-methyl-5-nitroquinoline 
(73), was dissolved in DMSO. One equivalent of iodine and 0.06 equivalents of ferrous 
chloride tetrahydrate were then added to the stirring reaction mixture, followed by 1.25 
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equivalents of TFA and 0.22 equivalents of tert-butyl iodide. The reaction was stirred for 7 
hours at 90 oC, but analysis by means of thin layer chromatography (TLC) showed the 
reference spot of the starting material and the reaction spot to be at the same Rf-value. It 
appeared that no reaction had occurred in the allotted time and the decision was made to 
stop the reaction. It was decided to quench the reaction and analyse it anyway, as there was 
a slight difference in the way the two spots fluoresced under ultraviolet light irradiation. The 
reaction mixture was diluted with distilled water and added to a stirring solution of saturated 
sodium thiosulfate. The acid in the reaction mixture was quenched with 10% w/v K2CO3 
solution and the product extracted with CH2Cl2. A small amount of the crude product was 
isolated, but analysis by 1H NMR showed that it was not in fact the desired product.  
 
Scheme 2.9: Oxidation of 6,7-Dimethoxy-4-methyl-5-nitroquinoline. i) FeCl2·4H2O, TFA, I2, t-
BuI, DMSO, 90 oC, 6 h. 
Since the first attempt was unsuccessful, even after following the literature procedure, it was 
decided to use different equivalents. The reaction was then attempted again, this time 
altering the order of the addition of the reagents. After first dissolving the quinoline (73) in 
DMSO, 0.52 equivalents of the ferrous chloride tetrahydrate was added, followed by 5 
equivalents of TFA and 1 equivalent of iodine. Finally, 2 equivalents of tert-butyl iodide were 
added. The reaction was stirred for 7 hours at 90 oC. Subsequent analysis by TLC showed 
no more starting material (which had a Rf-value of 0.45) and a spot on the base line. This 
was strange, as it would not be expected for there to be such a big difference in polarities 
between the starting material and product. The reaction was stopped and the work-up 
modified slightly. Instead of diluting the reaction mixture with distilled water, the saturated 
sodium thiosulfate solution was added to the reaction and then basified to pH 11 using 50% 
w/v sodium hydroxide solution. The product was then rigorously extracted with ethyl acetate 
and a very poor 42 mg of crude product was collected (compared to the 683 mg of starting 
material used for the reaction). The small amount of product was then analysed by 1H NMR 
spectroscopy, only for the spectrum to be unusable. Excessive line-broadening occurred and 
the characteristic aldehyde peak one would expect, was absent. This meant that the reaction 
had failed once more. Considering that the TLC showed a spot on the base line, it was 
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speculated that the oxidation might have somehow gone too far and that it could have 
formed the carboxylic acid instead. 
Thus, the reaction was attempted again on a 100 mg scale, but the reaction was monitored 
much more closely. The same equivalents of reagents were used, but the reaction was 
analysed by TLC after 2 hours. At this stage, the spot on the baseline had already formed – 
meaning the reaction might have over-oxidized already. The reaction was quenched the 
same way as in the previous attempt, delivering 44.7 mg of product. The crude product was 
analysed by 1H NMR spectroscopy and it appeared that some of the desired product might 
have formed, as a singlet appeared at 10.16 ppm in the 1H NMR spectrum that could have 
been indicative of an aldehyde. The sample was still very impure though, so purification 
would not give enough product to continue the synthesis. It was decided to monitor the 
reaction after 30 minutes instead and it was also decided to dry the DMSO over 4 Å 
molecular sieves. 
The reaction was again repeated with the same equivalents of reagents and monitored much 
more closely. This time, there was no spot on the base line and after 3 hours and 15 
minutes, analysis by TLC showed two spots at the same Rf-value that fluoresced differently. 
The two spots also reacted differently to the KMnO4-stain, with the spot of the reaction 
almost not reacting at all as opposed to the starting material developing in the stain. A part of 
the work-up was also modified to try and maximise the yield. The extractions were done with 
copious amounts of CH2Cl2 instead of using ethyl acetate. The CH2Cl2 fractions were 
combined and then washed with a large amount of distilled water, to remove most of the 
DMSO. The solvent was removed under vacuum to furnish 55 mg of crude product. The 
product was still impure and purification by chromatography would be impossible as the 
starting material had the same Rf-value as the product. The oxidation was starting to 
become a hindrance, as attempts to successfully utilise the procedure and optimization 
thereof, had been unfruitful. 
At this stage, other methods for oxidation were being considered, as well as a change in the 
order of the synthetic strategy. Firstly, it was decided to attempt the oxidation procedure on 
the methylquinoline (81, Scheme 2.10). The reaction was monitored by TLC and when it 
appeared to have reached completion, the reaction was worked up. Instead of basifying to a 
pH of 11 with 50% w/v sodium hydroxide solution, the reaction was basified to a pH of 8 with 
10% w/v K2CO3 solution. After this, 93 mg of product was isolated, but analysis by means of 
1H NMR spectroscopy showed that no reaction had occurred as it was all starting material 
(81).  
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Scheme 2.10: Oxidation of a different starting material. i) FeCl2·4H2O, TFA, I2, t-BuI, DMSO, 
90 oC, 6 h. 
Following the failure of this attempt as well, other methods were researched. One method for 
the oxidation of the methylquinoline (81) that was considered was based on a method 
reported by Trahanovsky and Young, which employed the use of cerium ammonium nitrate 
(CAN) in aqueous acetic acid to oxidize toluene (100) into benzaldehyde (101) in 92% yield 
(Shown in Scheme 2.11).51  
 
Scheme 2.11: Method for the oxidation of toluene to benzaldehyde that served as possible 
template for oxidation of our substrate. i) CAN, 50% aq. HOAc 
The method of Trahanovsky and Young was attempted on the substrate of interest (Scheme 
2.12), but this was unsuccessful, as the material appeared to have degraded. It was 
speculated that a possible product might have been the iminoquinone (102), amongst 
others. The reasoning behind this comes from considering similarities in the substrate (81) to 
that of the substrate in the unsuccessful synthesis reported by White et al. (compound 43, 
Scheme 1.2). These researchers also employed the use of CAN for the oxidation of the 
tetrahydroquinoline (43) and synthesized a compound (44) similar to what we postulated.  
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Scheme 2.12: Attempted oxidation procedure reported by Trahanovsky and Young applied 
to our substrate.51 i) CAN, 50% aq. HOAc, 100 oC, 5 h. 
The decision was made to have one last attempt at the oxidation procedure reported by 
Vismara et al..50 Considering the fact that it appeared that some over-oxidation might be 
occurring, it was decided to minimize the amount of water in the reaction.  The equivalents of 
ferrous chloride tetrahydrate were thus adjusted to 0.5 equivalents. This corresponded to 2 
equivalents of water being added to the reaction. To further ensure that the amount of water 
in the reaction was minimized, the DMSO was dried over 4 Å molecular sieves. The DMSO 
was then heated to 60 oC while the methylquinoline (73) was added. 0.125 Equivalents of 
the ferrous chloride tetrahydrate was then added, followed by the same equivalents of the 
other reagents as before: 5 equivalents of TFA, 1 equivalent of iodine and 2 equivalents of 
tert-butyl iodide. The reaction was then heated to 90 oC and stirred for 6 and a half hours. 
The reaction was then analysed by TLC and again, the spots for the starting material and 
proposed product were at almost the exact same Rf-value. Again, under ultraviolet light 
irradiation, there was a slight difference in the fluorescence of the two spots. The TLC was 
then stained using an iodine stain and it was noted that the starting material developed in 
the stain, whereas the product did not develop at all. For extra assurance and since iodine is 
a reversible stain, the TLC was also stained with p-anisaldehyde stain – which is selective 
for aldehydes. Upon heating the TLC plate, the product spot started turning yellow. The 
reaction was therefore deemed complete and worked up to give 209 mg of crude product. 
Analysis by 1H NMR spectroscopy confirmed that it was indeed the desired product, showing 
a singlet at 10.23 ppm that corresponded to the aldehyde proton of the literature value.40 
This also meant the product was isolated in an excellent yield of 99%.  
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The reaction was repeated many times and the yields then generally varied between 80 and 
95%. It should be noted that the amount of ferrous chloride tetrahydrate clearly had an 
influence on the success of the reaction, as using 0.125 equivalents delivered very high 
yields. This corresponded to merely half an equivalent of water, so the results seen up to this 
point which indicated a possible over-oxidation could have been influenced by an excess of 
water present. The initial report by Vismara and co-workers utilized 0.06 equivalents of 
ferrous chloride tetrahydrate (thus, 0.24 equivalents of water in the reaction), less than half 
of what we found to be efficient. Therefore it did seem that the amount of water added to the 
reaction in the form of the ferrous salt needed to be kept to a minimum. It should be noted 
that this was not stipulated or mentioned in the paper published by Vismara and co-workers. 
Following the success of the reaction and the high yields, the silver(II) oxide and IBX 
methods were not investigated. 
2.2.4 Protection of the aldehyde (84a,b) 
The next part of the synthesis involved the protection of the aldehyde functionality by forming 
the acetal (Scheme 2.13). Joule and co-workers formed the acetal (84a) by stirring up the 
aldehyde (83) in anhydrous methanol with an acid catalyst.40 Another member of our group 
had initially attempted the prescribed procedure for the formation of compound 84a, but it 
was found to be fairly inefficient.  
 
Scheme 2.13: Formation of the acetal 
Therefore, the decision was made to make use of an orthoester to generate the acetal. 
Methods of interest involved the use of trimethyl orthoformate (103, Scheme 2.14) in 
anhydrous methanol, in the presence of an organic acid such as camphor sulfonic acid or p-
toluene sulfonic acid, to generate the dimethyl acetal. The use of an orthoester in acidic 
medium served a dual purpose, as it acted as both a dehydrating agent and generated 
methanol in situ, as shown in Scheme 2.14. This favoured the forward reaction by limiting 
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the amount of water present for hydrolysis of the acetal. It also avoided the formation of an 
equilibrium, as it promoted the forward reaction along with the generation of more methanol. 
As the acetal is formed, the consumption of the alcohol by the aldehyde also favours the 
forward reaction of the hydrolysis of the orthoester (103). The organic acid first protonates 
one of the methoxy-groups of the orthoester, after which a lone pair of another oxygen kicks 
in to eliminate the first equivalent of methanol. The resulting oxonium species (104) then 
undergoes nucleophilic attack by a water molecule. This consumption of water by the 
orthoester also serves to inhibit the hydrolysis of the newly formed acetal and makes the 
forward reaction more favourable. An intramolecular proton transfer converted compound 
105 into compound 106, which can now eliminate another equivalent of methanol. By 
regenerating the acid catalyst, methyl formate (107) is formed as a by-product. 
 
Scheme 2.14: Mechanism for the hydrolysis of the orthoester 
Chao et al. reported using p-toluene sulfonic acid as catalyst, thus the consumption of water 
by the orthoester is especially beneficial as the acid is used in its monohydrate form.52 The 
mechanism for the formation of the acetal is shown in Scheme 2.15.  
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Scheme 2.15: Mechanism for the formation of the acetal. 
The reaction was then done by dissolving the aldehyde (83) in anhydrous methanol and then 
adding the orthoester (103) along with the acid catalyst. A nitrogen atmosphere was 
established and the reaction was stirred at 30 oC for 24 hours. After 24 hours though, TLC 
showed that the starting material was still present, so a nitrogen atmosphere was 
established again and the reaction heated to 60 oC and then stirred for 24 hours. Analysis by 
TLC then showed that the starting material had been consumed and the reaction had 
reached completion. The reaction was stopped and worked-up to give 94.3 mg of the crude 
product in a mere 38% yield. However, even this yield was not obtained as analysis by 1H 
NMR spectroscopy showed the product to contain a significant number of impurities that 
could not be identified. Nonetheless, the spectrum did show the peaks corresponding to the 
two methyl groups of the newly formed acetal at 3.31 ppm and the C-H proton peak of the 
acetal at 5.50 ppm. 
The reaction was then repeated using dry benzene instead of methanol and stirred at 60 oC 
for 48 hours before the reaction was stopped and worked-up. This time, the product was 
isolated in 82% yield, but again the 1H NMR spectrum showed there to be small amounts of 
impurities present. This problem persisted, so the decision was made to synthesize a 
different acetal. Instead of the dimethyl acetal, the dioxalanyl acetal was formed by stirring 
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up the aldehyde with ethylene glycol and an acid catalyst, thus generating compound 84b. 
The reaction was carried out in dry benzene using a Dean-Stark setup over a period of 72 
hours, after which the reaction mixture was concentrated under reduced pressure and the 
residue redissolved in 10% K2CO3 solution. The resulting solution was extracted with ethyl 
acetate to give compound 84b (Scheme 2.16) in 79% yield as a pure product, according to 
the 1H NMR spectrum. 
 
Scheme 2.16: Formation of the dioxalanyl acetal (84b). i) Ethylene glycol, p-TsOH, benzene, 
reflux, 72 h. 
The C-H peak of the acetal was visible at 6.18 ppm and the two methylene groups of the 
dioxalanyl ring overlapped with the peak for the two methoxy groups in the 6- and 7-
positions. The greater purity of the product obtained from this method made it preferable to 
the formation of the dimethyl acetal. The formation of the dioxalanyl acetal was driven by its 
superior stability to that of the dimethyl acetal. This increased stability was as much a 
disadvantage as it was an advantage, as it made the deprotection after the reduction step 
much more problematic. The reaction times had to be increased as the protonation of the 
dioxalanyl ring (compound 108, Scheme 2.17) led to the formation of the oxonium species 
109 that had two possible nucleophiles  ̶ the amine on the 5-position of the 
tetrahydroquinoline and the hydroxyl-group on the ethyl chain. The desired route is for the 
amino-group to attack the electrophilic site of the oxonium species (109) and thus lead to the 
formation of the ammonium species 110. But the reverse reaction – with the hydroxyl-group 
acting as nucleophile – is equally likely and the reaction would reverse to form compound 
108 again.  
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Scheme 2.17: Problem with the deprotection of the acetal 
Therefore the decision was made to investigate the use of a dimethyl acetal again and 
attempt to optimize the reaction conditions. The advantages of using an orthoester were 
considered again and a literature search was done. Yang et al.53 reported a procedure fairly 
similar to that of Chao et al.,52 but instead of using methanol as solvent, they merely used 
trimethyl orthoformate as solvent and methanol source. The aldehyde (83) was then 
dissolved in trimethyl orthoformate and 0.5 equivalents of p-toluene sulfonic acid 
monohydrate were added. The reaction was next heated to 100 oC and stirred for 24 hours 
to reach completion. After the reaction mixture was quenched with a saturated solution of 
sodium hydrogen carbonate, the product was extracted with ethyl acetate to give the pure 
dimethyl acetal (84a) in 92% yield (Scheme 2.18).  
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Scheme 2.18: Successful acetal formation procedure. i) Trimethyl orthoformate, p-TsOH, 
100 oC, 24 h. 
This procedure – with its high yield and purity – was then used. The different sources of 
alcohol for the formation of the acetals, along with which acid and solvent was used, is 
summarized in Table 2.2 below: 
Table 2.2: Different strategies attempted for the synthesis of Compounds 84a and 84b 
Entry Source of alcohol Acid Solvent Acetal 
Yield 
% 
1 Methanol Hydrochloric acid Anhydrous methanol 84a n/a 
2 Trimethyl orthoformate p-Toluene sulfonic acid Anhydrous methanol 84a n/a 
3 Trimethyl orthoformate p-Toluene sulfonic acid Benzene 84a n/a 
4 Ethylene glycol p-Toluene sulfonic acid Benzene 84b 87 
5 Trimethyl orthoformate p-Toluene sulfonic acid Trimethyl orthoformate 84a 92 
 
2.2.5 Reduction, ring-closure and selective methylation (85-87) 
Upon the successful synthesis of compound 84a in high yield and purity, it was used for the 
synthesis of the diamine 85a (Shown in Scheme 2.19). It should be noted here that 
compound 84b was also used in these reduction reactions, but as mentioned earlier, the 
complications that arose during the hydrolysis of the acetal rendered in ineffective as an 
intermediate in the synthetic strategy. Therefore the use of compound 84b and subsequently 
that of compound 85b will not be discussed, although it was used in reactions that attempted 
the construction of the tricyclic scaffold. The planned reduction of compound 84a was 
expected to bring about a large change in molecular properties, as not only the nitro-group 
would be reduced to an amine, but the aromaticity of the heterocyclic ring of the quinoline 
would be changed to produce a substituted aniline. The reduction was done by dissolving 
compound 84a in methanol along with the nickel(II) salt. Sodium borohydride was then 
rapidly added in portions to produce a highly exothermic reaction. Both the sodium 
borohydride and nickel(II) chloride hexahydrate were used in great excess. The reaction was 
started at room temperature, but after the addition of the sodium borohydride, the reaction 
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mixture could reach temperatures as high as 80 oC. Upon addition of the first portion of 
sodium borohydride, the mixture turned black and started giving off gas – which is most 
probably H2 as transition metals in the presence of sodium borohydride and water tend to 
evolve hydrogen gas from the reaction mixture.54 The black colour was due to the fine 
particles of the nickel borides, the Ni3B and Ni2B species, that formed as the sodium 
borohydride interacted with the nickel(II) salt in the alcohol medium.55 Nickel boride is a very 
active reducing agent with a selectivity for nitro-groups – even aliphatic nitro-groups – and C-
C unsaturations, but it is not strong enough to reduce carboxylic acids, esters or amides.56 
The reaction was stirred for 25 minutes after the addition of sodium borohydride, at which 
point the reaction mixture also stopped bubbling. The reaction mixture was subsequently 
quenched with distilled water and ethyl acetate was then added to the stirring mixture. The 
work-up was fairly difficult in terms of effective extraction as the black particles that formed 
were insoluble in the aqueous phase leading to a heterogeneous mixture. Initial attempts at 
filtering off the black solid proved troublesome as the fine particles packed very tightly during 
filtration by means of a sintered glass funnel, such that the filtrate could not pass through. 
When the product, using compound 84a as starting material, was finally isolated, it was a 
faint pink oil with an almost waxy consistency. It was stored below 0 oC overnight, but even 
at low temperatures, the product seemed prone to degradation. The colour changed from the 
waxy, light pink to a strong dark pinkish purple colour overnight.  
This product was analysed by means of 1H NMR spectroscopy, but the product had 
degraded and the spectrum was unusable. When the reaction was repeated, it was noticed 
that the colour of the organic layer also started changing during the course of the extraction. 
The organic layer started off as colourless, but as the work-up continued, the organic layer 
started to darken and started resembling the colour of the degraded product. The work-up 
was continued, but the colour had changed to a very dark pinkish red and analysis by means 
of 1H NMR spectroscopy showed that the product had degraded. It was speculated that the 
resulting diamine (85a) was fairly sensitive to oxidation when exposed to air. This seemed to 
be supported by the fact that the first attempt saw the degradation of the product when 
stored under normal atmosphere below 0 oC. Due to the apparent sensitivity of compound 
85a, it seemed more logical to only isolate the product after the following step – thus, only 
isolate the product after the ring-closing step, i.e. isolate the indole 86. The indole was to be 
generated by stirring up the intermediate 85a in acidic medium. Various strategies were 
attempted, but the first was the strategy proposed by Joule and co-workers.40 In their 
approach, the diamine (85a) was stirred up in aqueous 1 N hydrochloric acid in THF at 40 oC 
for 1 hour to afford the indole in a respectable 64% yield.  
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Scheme 2.19: Reduction of the acetal and subsequent ring-closure to form the indole and 
proposed aniline methylation. i) NiCl2·6.H2O, NaBH4, MeOH, rt, 15 min; ii) [H+] 
This approach was therefore followed on the acetal (84a) and after an hour and 30 minutes 
at 40 oC, no real change was observed. The reaction temperature was then increased to 65 
oC, but analysis by means of TLC showed multiple spots and it seemed degradation had 
occurred. The reaction was attempted again, this time the acetal was dissolved in methanol 
and the nickel(II) salt added. The addition of sodium borohydride again turned the reaction 
mixture black as the nickel boride formed. After the addition of all the sodium borohydride, 
the reaction mixture was left to stir until it stopped bubbling and the reaction was then 
quenched with distilled water. The reaction mixture was immediately filtered through a 
sintered glass filter, again proving difficult, as the small, black nickel boride particles packed 
very tightly and blocked the frit of the sintered glass filter, slowing down the filtration. The 
filtrate was then extracted with CH2Cl2 and the organic layer collected, dried and evaporated 
under reduced pressure. The residue was then redissolved in aqueous 2 N hydrochloric acid 
and stirred at 60 oC for 3 hours. When analysed by TLC though, four spots had formed 
again, but unlike the earlier attempt, these spots looked to be more easily separated by 
column chromatography.  
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Firstly, a crude 1H NMR spectrum was obtained of the extracted products, rather than 
investing time in purification. From this crude 1H NMR spectrum, some signals suggested 
that the desired product was in fact present, namely: the two triplets corresponding to the 
two methylene carbons (numbered 1 and 2 in Spectrum 2.3), the two aromatic singlets 
corresponding to the tetra-substituted indole (numbered 3 and 4 in Spectrum 2.3) and finally 
the two methyl groups of the methoxy substituents (numbered 5 and 6 in Spectrum 2.3). 
There were also methoxy-peaks present in the crude sample that did not appear in the 
spectra of the purified products that were collected. It is unclear what happened to these 
spots  
 
Spectrum 2.3: Crude 1H NMR spectrum of the ring-closing reaction 
The crude product was then purified by means of column chromatography, using a gradient 
elution. The top two spots on the TLC (which required the use of a solvent system of 10% 
methanol/ethyl acetate as eluent), were collected by using a solvent system of 5% 
methanol/ethyl acetate as eluent and the third spot was collected using a 15% 
methanol/ethyl acetate solvent system as eluent. The fourth spot observed on the TLC plate 
was not collected, as it did not elute when using the polar 15% methanol/ethyl acetate 
solvent system as eluent. All three of the spots that were collected, were analysed by means 
of 1H NMR spectroscopy and unfortunately the structures of the first two spots could not be 
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elucidated from their NMR spectra, as these were complex and no structural information 
could be obtained from them. Significantly, the peaks of the third NMR spectrum matched up 
with the peaks identified in the crude spectrum. The 1H NMR spectrum showed broadening 
of the peaks, which could not be removed by any processing and the area under these 
peaks could not be integrated. The chemical shifts did however correspond to the peaks 
identified in the crude reaction mixture. The reaction was repeated and purified by means of 
column chromatography to again produce the product, this time in a 19% yield, which 
delivered a much more interpretable 1H NMR spectrum (Spectrum 2.4). It should be noted 
here, that the deuterated solvents used in our experiment differed from those reported in the 
literature, as the literature spectrum was recorded in deuterated chloroform and we used a 
mixture of deuterated chloroform and DMSO due to the sparing solubility of the product in 
deuterated chloroform. However, when the chemical shifts of the peaks of this spectrum 
were compared to those reported in the literature, it was found that the peaks in the aliphatic 
region did not match up to that of the expected product. The triplet signal at a chemical shift 
of 2.78 ppm, was close to that reported in the literature – 2.99 ppm – for the expected 
product 86. The other triplet signal, which was expected to appear at a chemical shift of 3.50 
ppm, appeared much higher at a chemical shift of 4.15 ppm. This meant that this was in fact 
not the desired product (this was confirmed by 13C NMR spectroscopy, which is discussed 
later).40 Analysis of this sample by means of 1H NMR spectroscopy introduced more 
discrepancies between the spectrum of our product and that reported for compound 86 – the 
peaks did not match up and extra splitting appeared on the signals. Closer inspection also 
revealed that this splitting pattern had occurred with all proton signals (Shown on Spectrum 
2.4). The area under the proton signals were integrated and the signal at 3.75 ppm, which 
would be expected to be equivalent to 6 protons for the two methoxy groups, only integrated 
for 3 protons. This indicated a possible loss of a methyl-group. The other peaks did integrate 
for their expected values, which lead us to believe that this compound might be related to the 
desired product. Due to the darkening of the colour during column chromatography, an 
oxidation was considered as a possible side reaction since SiO2 has been reported to act as 
a mild oxidant.57  
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Spectrum 2.4: 1H NMR spectrum of the compound at first thought to be compound 86.  
*It should be noted that an unexplained doubling up of the peaks in the spectrum occurred. 
Due to the instability of the product, the spectrum could not be rerun. These are not present 
in the 13C NMR spectrum. 
The 13C NMR spectrum was also obtained and inspected (Spectrum 2.5), so as to gain 
insight into the possible structure of the compound which had formed. Upon inspection, a 
carbon signal in the aliphatic region was also unaccounted for, which confirmed the 
suspicion that a methyl-group had been “lost” during the reaction.  
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Spectrum 2.5: 13C NMR spectrum of the compound. 
As an oxidation was suspected to have been possible, the NMR spectroscopic data of the 
known 7-methoxypyrroloiminoquinone (78) was inspected. Of significance was that the 
chemical shift values of the spectrum compared very well to that reported in the literature.40 
The chemical shifts of the signals in the 1H NMR spectrum were 0.08 – 0.15 ppm from that 
of the literature value. It must also be noted that the literature spectrum was recorded in 
CDCl3, but in our analysis, as the product was only sparingly soluble in this solvent, 
deuterated DMSO was added to aid in dissolving the compound. The difference in the 
values of the 13C NMR spectrum and that reported in the literature was also off by 1 – 2 ppm 
(these results are summarized in Table 2.3).  
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Table 2.3: Comparison of chemical shifts of compound 78 as reported in the literature and 
experimentally determined during this study.40 
 
1H NMR Chemical shifts (ppm) 
 
Lit.40 Multipl. Exp. Multipl. 
 
6.92 s 6.77 2 x s 
 
6.14 s 5.99 2 x s 
 
4.19 t, 7.9 Hz 4.05 2 x t, 7.9 Hz 
 
3.84 s 3.74 2 x s 
 
2.78 t, 7.9 Hz 2.68 2 x t, 7.9 Hz 
 
13C NMR Chemical shifts (ppm) 
 
Lit.40 Exp. Lit.40 Exp. 
 
171.5 169.9 117.5 115.8 
 
158.8 157.8 106.8 105.2 
 
156.9 156.0 56.9 55.6 
 
124.3 123.2 51.4 50.6 
 
123.1 122.3 18.8 17.6 
 
121.8 120.3     
 *Literature NMR spectra recorded in CDCl3 whereas experimental data recorded in 
CDCl3/DMSO-d6. Experimental 1H NMR spectrum also showed unexplained doubling of 
peaks, as mentioned below Spectrum 2.4. 
This means that during the purification (possibly even during the reaction), an unexpected 
additional reaction had occurred – namely, the oxidation of the desired product (86) into the 
pyrroloiminoquinone 78 (See Scheme 2.20). This unexpected reaction was of course 
problematic, as the N-methyl group necessary to construct the makaluvamine G analogues, 
had not yet been introduced. 
 
Scheme 2.20: Reaction scheme of side reaction that occurred. i) NiCl2.6.H2O, NaBH4, 
MeOH, rt, 15 min; ii) [H+]. 
Considering the lack of success in generating the indole scaffold (compound 86), different 
methods for achieving the ring closure were attempted, starting with the reduction of the 
acetal (84a) and optimization thereof. Different strategies for acidifying the resulting diamine 
(85a) were then investigated. Instead of acidifying the product (85a) under aqueous 
conditions, after the reduction was quenched and extracted with ethyl acetate, the residue 
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that was left when the ethyl acetate was removed under reduced pressure, was redissolved 
in dry THF. One equivalent of p-toluene sulfonic acid was added, a nitrogen atmosphere 
established and the reaction was stirred at room temperature for 17 hours. But, even then, 
no product had formed judging by the thin layer chromatograph analysis. The reaction was 
then heated to 65 oC and stirred for another 5 hours, but still no product had formed. The 
same procedure was repeated again, but the reaction mixture with p-toluene sulfonic acid 
was heated to 65 oC overnight instead of stirring it at room temperature. The reaction was 
again unsuccessful, as the 1H NMR spectrum of the crude product did not show any of the 
expected peaks of the indole product (86). 
The reduction of the acetal (84a) was then repeated, but in attempt to slow down the 
reaction, the reaction mixture was cooled down to -20 oC using a crushed ice and coarse salt 
ice bath. Upon the completion of the reduction step, the reaction mixture was diluted with 
diethyl ether and the ether layer was isolated. This ether layer was acidified by using 
hydrochloric acid gas, which was generated by adding concentrated sulphuric acid to sodium 
chloride and bubbling the gas through the solution of ether and crude product. The hope was 
that if the ring closure did not occur, the diamine (85a) could at least be isolated as the 
corresponding ammonium salt. 
As soon as the acid started bubbling through the ether, two layers formed. A small yellow 
layer formed at the bottom, which was suspected to be an aqueous layer containing the 
newly formed ammonium salts. Another possibility is that it could also be an immiscible salt 
that appears as an oily residue. This proved that it was imperative to thoroughly dry the ether 
layer after extraction. The ether was removed under reduced pressure to leave the 
suspected water layer. A colour change was observed whilst the reaction mixture was on the 
rotary evaporator: the yellow turning maroon and finally dark brown. This suggested that the 
ring closure had started taking place in the acidic conditions, therefore two drops of sulfuric 
acid were added to the mixture and left to stir at room temperature. An analysis by means of 
1H NMR spectroscopy indicated the formation of the indole, although the spectrum was very 
impure. Two singlets that correspond to the two methoxy groups of tetrahydroquinoline 
scaffold were present. It was very difficult to conclusively identify any other characteristic 
peaks in the aliphatic region due to a multitude of peaks present. The protons of the two 
methylene groups on the tetrahydroquinoline structure could therefore not be clearly 
identified for confirmation of the ring closure. The attempted synthesis of compound 86 was 
again unsuccessful. 
The reduction and subsequent acidification of compound 84a to synthesize compound 86 
was attempted again, this time with the only difference that the ether layer was dried over 
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anhydrous magnesium sulphate to avoid the formation of two immiscible layers again. This 
did not prove to be sufficient though, as on commencement of the acid addition, small 
orange droplets formed. These became darker in colour with time. The mixture was then 
quenched with a solution of saturated sodium bicarbonate. Upon addition, the ether layer 
became a milky orange, then turned green and finally dark orange. The ether layer was 
isolated and dried overnight over anhydrous magnesium sulphate so as to dry the organic 
layer. When the isolated crude product was finally analysed by 1H NMR spectroscopy, it 
turned out not to be the desired product. The presence of water in this procedure does seem 
to cause some problems. Therefore, it is important to attempt to keep this step as water-free 
as possible and to minimize the amount of oxygen to which the reaction mixture is exposed. 
Since repeated attempts to synthesize the indole had been unsuccessful, the isolation of the 
diamine 85a was attempted (Shown in Scheme 2.23). Therefore, the reduction with nickel(II) 
chloride and sodium borohydride was repeated. This new attempt was with a new batch of 
nickel(II) chloride, as well as a new bottle of methanol (both ordered from Sigma Aldrich), 
with the main difference being that the methanol was used without further purification or 
drying, whereas the previous attempts involved the use of anhydrous methanol. The sodium 
borohydride pellets were also crushed to a fine powder, instead of just being broken down 
into smaller pieces. The acetal was then dissolved in the commercial methanol and the fine 
sodium borohydride powder added rapidly in small portions.   
 
Scheme 2.21: The reduction of quinoline (84a) giving rise to the tetrahydroquinoline (85a). i) 
NiCl2.6H2O, NaBH4, MeOH, rt, 15 min. 
Over various attempts, the yields attained using this method were as high as 94%. One of 
the ways this was achieved was by changing the sintered glass funnel used for the removal 
of the black nickel boride particles. The frit of the sintered glass funnel that was initially used 
had a porosity of 4, so it was later repeated but with a sintered glass funnel with a porosity of 
0. The filtration was then done using a pad of cotton wool and the filtrate was collected with 
ease. The colour change was minimal when the reaction was rapidly filtered. It was also 
noted that the diamine (85a,b) – even though sensitive to oxidation – could be safely stored 
for three to four days, by storing it under a nitrogen atmosphere below 0 oC. 
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The successful synthesis of compound 85a, made it possible to focus attempts on the 
synthesis of the indole (86) again. The dioxalanyl acetal was then deprotected using a 
procedure reported by Schlosser and co-workers, but again, the procedure proved inefficient 
for this substrate.58 According to the procedure followed, the acetal had to be stored in 2 M 
hydrobromic acid for 24 hours. Instead of simply storing the compound in acid, the reaction 
was stirred for the same amount of time at room temperature, but the reaction did not 
proceed. Upon heating, the reaction did proceed but also degraded the organic material, 
therefore rendering the method ineffective. 
Considering the lack of success in synthesizing the indole (86), the authors of the paper that 
initially reported the synthesis of this product were contacted.40 Professors Joule and Alvarez 
responded and confirmed what our research had been suggesting up until this point.59 
According to Professor Alvarez, in their experience as well, the indole was very unstable and 
tended to degrade under reaction conditions. The researchers attributed this to the benzene 
ring being very electron rich, due to the methoxy- and nitrogen substituents on the ring. This 
supported our findings where significant colour changes occurred when handling the indole. 
These researchers then supplied us with the experimental sections of the thesis of two of 
their students who had worked on the results published in this paper. Due to the confirmed 
instability of compound 86, the decision was made to reconsider the synthetic strategy and 
alter it in order to avoid the synthesis of the indole (86).  
2.2.6 Reconsideration of the synthetic route 
The initial aim was to introduce a methyl group onto the anilino-nitrogen of the indole and 
synthesize compound 87, but the poor stability of compound 86 made it impossible to 
continue the initial synthetic strategy. Therefore, the decision was made to introduce the 
methyl group at an earlier stage in the synthetic strategy. The method considered was the 
methylation of the quinoline 84 to produce the quinolinium species 111 (Scheme 2.24). 
Reduction of this compound would then give rise to the N-substituted diamine 119. 
Compound 87 would then be synthesized using the same procedure initially attempted for 
the synthesis of indole 86 – by deprotecting the acetal under acidic conditions. There were 
concerns, however, that there might not be a marked improvement in the stability of 
compound 87 over that of compound 86. The extra inductive effects of the methyl group 
could increase the electron density in the benzene ring even further. It was hoped that the 
tertiary amine moiety might be more stable under the reaction conditions though. Upon the 
successful synthesis of compound 87, the synthetic strategy would then continue as initially 
planned with the oxidation to compound 72 and subsequent substitution. 
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Scheme 2.22: Reconsidered synthetic strategy 
The revised strategy was then started by the methylation of the quinoline (84). 
2.2.7 Methylation of the quinoline (111) 
The methylation was done according to a procedure reported by Joule and co-workers.40 
Compound 84 was dissolved in dry CH2Cl2 and methyl iodide was added. The reaction was 
stirred at room temperature for two days to produce the product in a low yield of 28%. The 
quinolinium iodide (111, Scheme 2.25) was isolated by removing the solvent under reduced 
pressure and the residue product washed with benzene to remove any remaining starting 
material, unfortunately the 1H NMR spectrum indicated that there was still starting material 
present. The presence of the starting material in the NMR sample was attributed to the fact 
that the residue was not washed thoroughly enough with benzene. When initially 
concentrated in vacuo, some of the starting material could have been trapped in the residue 
product along with the product and could not be washed out. The decision was, therefore, 
made to alter the reaction conditions by changing solvents. 
Since the starting material and the product are both soluble in dichloromethane, the decision 
was made to use toluene instead as the starting material is soluble in this solvent, but the 
chosen product was expected not to be. Therefore, taking advantage of the charge of the 
molecule to increase the ease of purification of the reaction, the reaction was reattempted. 
The starting material was dissolved in toluene and an excess of methyl iodide was added. 
The reaction was then left to stir for four and a half days. During this time, the colour of the 
reaction mixture changed from dark orange to a very faint orange-yellow and a residue 
formed on the sides of the round-bottomed flask. The work-up of the reaction involved 
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decanting off the mother liquor of the reaction and repeatedly rinsing the reaction with 
portions of toluene and then drying under high vacuum.  
 
Scheme 2.23: Methylation of the quinoline to form the quinolinium salt (111). i) MeI, Toluene, 
35 oC, 4 days. 
The desired product was isolated as an orange powder and analysis by 1H NMR 
spectroscopy confirmed that it was the product, as evidenced by the down-field shift of the 
doublet signal of the proton ortho to the N-methyl group to 9.45 ppm. The protons of the new 
methyl group were also visible, resonating at a chemical shift of 4.64 ppm (Shown in 
Spectrum 2.7). The product was isolated in 44% yield. 
 
Spectrum 2.6: 1H NMR spectrum of the methylated quinoline (111) 
2 
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2.2.8 Reduction and ring-closure of the quinolinium species (112 
& 87) 
Upon the successful methylation of the quinoline to produce compound 111, the reduction of 
the nitro-group and quinoline was performed. This was done with the same degree of 
success as when using the unmethylated substrate. The conditions and ratios used were 
exactly the same as described for the successful reaction in Section 2.2.5 and will therefore 
not be repeated here. Yields for this reaction ranged from 80 to 93%. Instead, synthetic 
attention was focused on the construction of the elusive indole and the diamine was 
subjected to acidic conditions. The methods attempted were the initial one reported by Joule 
and co-workers (the use of aqueous 2N hydrochloric acid in THF), as well as the use 
hydrochloric acid gas generated in situ using sodium chloride and sulfuric acid.  
 The reduction of compound 111 also gave rise to a waxy compound, very similar to 
compound 85a. The difference in appearance between the two compounds was that 
compound 85a was a light pink waxy residue, whereas compound 112 was greenish-brown 
in colour. The first attempt at the ring-closure involved the use of the procedure by Joule and 
co-workers, using aqueous 2 N hydrochloric acid in THF. This procedure yet again proved to 
be inefficient, as no progress in the reaction was noted after stirring for three hours at room 
temperature and elevation of the temperature merely caused significant material 
degradation. The yellowish-brown reaction mixture started to darken and finally turned black. 
Considering the repeated failures utilizing this procedure, the decision was made to finally 
abandon this method of ring-closure, as it seemed to be unsuccessful when utilizing both 
compound 85a and compound 112 as substrate. 
The ring-closure was then attempted again, but using hydrochloric gas generated in situ 
instead. Compound 112 was redissolved in diethyl ether and the acid was bubbled through 
the mixture whilst stirring (Scheme 2.26). The reaction mixture at first went milky and when 
left for a 20 minutes, a precipitate crashed out. This was attributed to possible formation of 
the hydrochloride salt of the diamine (112). When left to stir, the ring-closure is suspected to 
occur, since the precipitate started redissolving. 
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Scheme 2.24: Conditions for the revised synthetic route. i) NiCl2.6H2O, NaBH4, MeOH, rt, 15 
min; ii) [H+]. 
Considering the mechanism of the ring-closure reaction (Scheme 2.27): if a proton transfer 
happened with the hydrochloride salt of the diamine 112 – the ammonium salt could 
tautomerize to the oxonium species, which could be followed by the ring-closure. Methanol 
could then be eliminated from the oxonium intermediate to form the methyl oxonium species 
(113). This electrophilic species could then undergo an intramolecular nucleophilic attack 
and the neighbouring amine moiety acts as a nucleophile, to form the basis of the tricyclic 
structure (114). The elimination of the second equivalent of methanol produces the 
intermediate 115 which through an isomerization would then form the indole (87). 
This seems to be what is occurring in the reaction mixture, considering the disappearance of 
the precipitate. As mentioned earlier, with the synthesis of the unsubstituted indole (86), 
these indoles seem to be prone to degradation under reaction conditions. The same 
appeared to apply to the substituted indole (87), as a prolonged exposure to the acidic 
medium seemed to destroy the substrate. The colour of the reaction mixture darkened and 
then turned black. When the reaction mixture turned black (or darkened) in the synthesis of 
the indole 86, the reaction had failed. The same occurred during this reaction. 
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Scheme 2.25: Mechanism of the ring-closing reaction 
Since there was a window in the reaction before the colour started to darken and, ultimately, 
turn black, the decision was made to repeat the reaction. When the reaction was repeated, 
the changes during the acid step were closely monitored. The precipitate formed first and 
was then left to stir until it dissolved again. After this, the reaction mixture was concentrated 
under reduced pressure. Here, again, as the mixture started to get more concentrated due to 
the removal of the diethyl ether, the colour change started. When all of the diethyl ether was 
removed, the oil that remained was a dark brown. This was concerning, as all evidence so 
far had indicated that the darkening of the colour was indicative of degradation.  
Instead of spending more time on attempting to isolate compound 87, the decision was 
made to use the crude product directly for the subsequent step and purify only once the 
oxidation had been done (Scheme 2.28). The crude mixture was redissolved in dry 
acetonitrile and cerium ammonium nitrate was added to the reaction mixture. After 30 
minutes, the starting material had disappeared (when the reaction mixture was analysed by 
means of TLC) and the reaction was stopped. The work-up proved a challenge, as the 
expected product (72) is a charged species and possibly water soluble. Also, an exhaustive 
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literature search on the purification of the charged analogues proved unfruitful, as most 
syntheses focused on the synthesis of the unmethylated 7-methoxy analogue (78) instead of 
the quaternized imminium quinone (72). An analysis of the crude product (with cerium 
ammonium nitrate anion as counter ion) by 1H NMR spectroscopy was unfruitful, as the 
counter ion appeared to distort the spectrum. The removal of this counter ion seemed to be 
essential.  
Scheme 2.26: Attempted synthesis of the indole (87) and subsequent oxidation. i) HCl (g), 
Et2O, rt; ii) CAN, MeCN, rt, 30 min. 
The decision was made to attempt the removal of the cerium complex counter ion through 
the use of an anion exchange resin. This resin is expected to retain the positively charged 
pyrroloiminoquinone species whilst the unwanted counter ion is flushed out (Figure 2.3). As 
no anion exchange resins were available, a Dowex® strong acid resin was repurposed to act 
as a cation retaining resin. This was done by stirring the resin in a sodium hydroxide solution 
overnight and then washing the resin with distilled water until all the base had been 
removed. The crude mixture containing compound 72 was then dissolved in methanol to dry 
load it onto the resin beads. The resin was loaded onto a column and also washed with 
copious amounts of distilled water. Acidic methanol (prepared by generating hydrochloric 
acid gas and bubbling it through methanol) was used as eluent, which would then protonate 
the resin causing the product to elute as the chloride salt. 
 
Figure 2.2: A diagrammatic representation of the preparation of the resin. 
An issue that arose with using the repurposed resin, in that the elution also flushed a large 
amount of sodium chloride from the column. The sodium chloride was removed by dissolving 
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the residue in freshly distilled anhydrous methanol, which caused the sodium chloride to 
precipitate out. When the compound obtained after the removal of the solvent was analysed 
by 1H NMR spectroscopy, none of the characteristic peaks were visible. This procedure was 
tried a second time as well, unfortunately with the same results.   
At this point, the project was concluded due to time constraints, as the synthesis and 
exploration of different routes to reach the target compounds could unfortunately not be 
done before the hand in date. Various strategies to overcome the challenges that have so far 
been identified in this project were however considered and will be discussed in Section 3.2 
– Future Work. 
In our opinion, the work done in this study will add to the literature on makaluvamines as it 
highlights shortcomings in a number of the synthetic strategies. With regards to the synthetic 
strategy ultimately followed, the first half of the synthetic procedure has been optimized to 
deliver good to excellent yields for the individual steps – in many cases improving on the 
literature reported yields. Also, in a number of cases, more efficient methods of synthesis 
and isolation have been identified. This present study also highlighted and explained some 
of the shortcomings in the literature, particularly where synthetic procedures were not 
properly described or too vaguely alluded to. Although the latter portion of the envisioned 
project was not successfully completed, the strategies to overcome the problems identified 
have been considered and will form part of the discussion under the section “Future work”.  
The project will still receive attention and hopefully will be able to deliver the compounds 
targeted at the onset. These synthetic results along with the biological evaluation results, will 
however, not form part of this dissertation. 
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Chapter 3 
3.1 Conclusion 
This project attempted the synthesis of three makaluvamine-analogues (88-90, Figure 3.1) 
and the generation of a possible small library upon successful synthesis of these 
compounds. The project was not successful yet, due to one weak point in the synthetic 
strategy, but continued attempts at the optimization of the synthetic method, could yet deliver 
these compounds. 
 
Figure 3.1: Makaluvamines-analogues that were to be synthesized 
The initial failure to generate these compounds just further highlighted the need for efficient, 
concise and short synthetic procedures to generate compounds of interest, as from a 
medicinal standpoint, the success of an anticancer agent can be undermined if the synthetic 
route to these compounds are long and inefficient. Thus, even though our probe into a 
shorter and more efficient route to 1-N-methylated makaluvamines (1-position shown on the 
general makaluvamine scaffold in Figure 3.1) had been unsuccessful, it has offered insight 
into how some of the issues can be overcome. These strategies will be discussed under 
future work, as they could not be completed within the time-frame of this study. 
Makaluvamines are a fascinating class of compounds that still have much to offer in terms of 
anticancer research. Of the many analogues that have been isolated, synthesized and 
tested, many have been shown to rival the current clinical agents such as etoposide (25) and 
amsacrine (26) (Shown in Figure 3.2). Therefore, by experimenting with different substitution 
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patterns on these makaluvamines and generating new libraries of analogues with novel 
groups in the 7-position, even more effective antiproliferative agents could be discovered. 
Combine this with further probes into the mechanism of action of these compounds, they 
could serve as potent anticancer agents. 
 
Figure 3.2: Current clinical topoisomerase II poisons 
3.2 Future Work 
Our future work involves reconsidering the synthetic strategy once more. The synthetic 
strategy devised by Joule and co-workers for the synthesis of damirones has been identified 
as a possible way of avoiding the very unstable indole (86, Scheme 3.1).48 This strategy 
provided the methylated indole (87) by going via the quinolinium species (113). The 
researchers reported generating this species by methylating compound 83 by using 
trimethyloxonium tetrafluoroborate. This group reported that the use of methyl iodide was 
ineffective and attributed this to the electron-withdrawing properties of the aldehyde. What 
was an interesting aside, was that they reported doing the reduction on the quinolinium 
species (116) without protecting the aldehyde. This had the effect that the reaction did not 
stop at the diamine (117), but that it immediately underwent the ring-closure to afford 
compound 87. Our aim is to use this strategy and immediately oxidize compound 87 to 
afford the 7-methoxy pyrroloiminoquinone (72).  
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Scheme 3.1: Future strategy to be attempted. 
The methylation strategy would be done using trimethyloxonium tetrafluoroborate as 
mentioned above, in CH2Cl2 at room temperature, as shown below in Scheme 3.2. 
 
Scheme 3.2: Methylation of the quinoline to be attempted. i) (Me3O+)BF4-, DCM, rt, 24 h. 
The methylation would then be followed by the reduction method, using NiCl2.6H2O and 
NaBH4 that had been used very successfully during this project. 
 
Scheme 3.3: Efficient reduction technique applied to the new quinolinium substrate. i) 
NiCl2.6H2O, NaBH4, MeOH, rt, 15 min. 
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Another issue that arose during the project was the removal of the cerium complex as 
counter ion after the CAN oxidation; therefore oxidation conditions will also be reconsidered. 
Cerium ammonium nitrate is a one-electron transfer oxidant, thus generating the Cerium(III) 
complex as counter-ion.  
 
 
Scheme 3.4: One-electron transfer oxidation using cerium ammonium nitrate 
Attempts to remove this compound have so far been unsuccessful in our hands, but more 
strategies to solve this problem are possible. These include trying to do an exchange with a 
more lipophilic counter-ion that would cause the product to partition into a more hydrophobic 
solvent. Counter-ions that are of interest are the PF6- anion and the tosylate anion. The other 
option is to use a different oxidant, one that might be easier to remove after the oxidation. 
The best candidate seems to be chloranil (118). The reduction of chloranil gives the radical 
species 119 as side product (shown in Scheme 3.5), which can be quenched to form the 
phenolic species, compound 120. This should be more easily removed by using a suitable 
organic solvent. 
 
Scheme 3.5: Reduction of chloranil when acting as oxidant 
Once this procedure had been successfully carried out, the final substitution (as shown in 
Scheme 3.6) with the amines of interest can be done [example shown with benzylamine 
(121) acting as nucleophile to produce target compound 88]. 
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Scheme 3.6: Substitution of the 7-position 
Once these compounds have been successfully synthesized, they will be sent to our 
collaborators for biological testing – not just for their anticancer activity, but also the mode of 
action of these compounds will be studied. The results of the planned biological tests could 
add to the literature on these compounds and aid in the development of these compounds 
as clinically viable agents, as the understanding of the mode of action of these compounds 
could lead to the development of more suitable clinical trials.15  
Once the synthetic procedure to afford the methylated pyrroloiminoquinone precursor had 
been fully optimized, a library of makaluvamine C analogues could be generated to further 
investigate the effect of substitution of the 7-position. These could possibly later be used to 
generate structure activity relationship (SAR) data for these compounds. 
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Chapter 4 
4.1 General information regarding experimental 
procedures 
4.1.1 Chemicals and solvents 
The chemicals used in this study were either purchased from two suppliers, Sigma Aldrich 
and Merck, or the chemicals from the De Beers Building chemical stores were used. Ethyl 
acetate, CH2Cl2 and hexane were distilled open to the atmosphere before use and were 
used for TLC plate separation and column chromatography. The solvents used for reactions 
were distilled under inert conditions over a suitable drying agents: CH2Cl2 and acetonitrile 
over calcium hydride, toluene and tetrahydrofuran (THF) over sodium (benzophenone as 
indicator for the THF still). These solvents were also stored over 4 Å molecular sieves when 
distilled.  
4.1.2 Laboratory equipment and consumables 
Reactions were heated in oil baths (either silicon oil or paraffin oil) using magnetic heater 
stirrers equipped with temperature probes. Solvents were removed under reduced pressure 
using Büchi RII Rotovapor rotary evaporators with Büchi V-700 Vacuum Pumps, equipped 
with V-850 Vacuum controllers, and the final trace amounts of solvents were removed by 
means of an Edwards high vacuum pump, capable of sustaining a vacuum of 0.08 mmHg. 
Glassware was dried in an oven at a temperature of 110 oC. Compounds were stored in 
Bosch refrigerators and freezers, which were kept at 2 oC and -22 oC, respectively. 
Machery-Nagel ALUGRAM® Xtra SIL G UV254 aluminium sheets were used for thin layer 
chromatography (TLC) analyses and a 254 nm UV light used for visualization. Various stains 
were used for the permanent development of TLC plates, including ninhydrin, potassium 
permanganate, cerium ammonium molybdate and p-anisaldehyde. Iodine was used as a 
reversible stain. Column chromatography was done with Merck silica gel (particle size range 
of 0.063-0.200 mm with 60 Å pores). 
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4.1.3 Analysis equipment 
NMR spectra were recorded on the instruments of the Central Analytical Facility (CAF) of 
Stellenbosch University. A 300 MHz Varian VNMRS spectrometer and a 400 MHz Varian 
Unity Inova spectrometer were used for the recording of 1H NMR spectra (75 MHz and 101 
MHz on these two instruments respectively for 13C NMR spectra).  
4.2 Experimental Procedures 
4.2.1 Experiments pertaining to Section 2.2.1 – Synthesis of the 
quinoline (81) 
4.2.1.1 Synthesis of 6,7-Dimethoxy-4-methylquinoline (81) 
Iron(III) chloride hexahydrate (9.3 g, 0.034 mol) was dissolved in 
glacial acetic acid (100 mL) at 60 oC. When all of the Iron(III) 
chloride had dissolved, 3,4-dimethoxyaniline (5.0 g, 0.033 mol) was 
added. Methyl vinyl ketone (3.8 mL, 0.045 mol) was then added 
over 25 min. When all of the methyl vinyl ketone had been added, the temperature was 
raised to 140 oC and stirred for 2 h 15 min. The reaction was adjudged to have reached 
completion by means of TLC and cooled on ice. The cooled reaction mixture was then 
concentrated under reduced pressure to remove the acetic acid, leaving a brown precipitate. 
The precipitate was added to a mixture of saturated NaHCO3 (250 mL) and extracted with 
EtOAc (6 x 60 mL). The EtOAc was removed under reduced pressure to give 5.54 g of 
product (84%). 1H NMR (400 MHz, CDCl3) δ 8.60 (d, J = 4.5 Hz, 1H), 7. 46 (s, 1H), 7.20 (d, J 
= 4.5 Hz, 1H), 7.18 (s, 1H), 3.99 (s, 3H), 3.97 (s, 3H), 2.65 (s, 3H). 13C NMR (101 MHz, 
CDCl3) δ 152.2, 149.7, 148.1, 145.2, 142.6, 123.7, 120.7, 108.7, 101.7, 56.3, 56.2, 19.1.48 
Spectrum compares well to spectrum reported in the literature. 
4.2.2 Experiments pertaining to Section 2.2.2 – Selective nitration 
of the quinoline (82) 
4.2.2.1 Synthesis of 6,7-Dimethoxy-4-methyl-5-nitroquinoline (82) 
Fuming Nitric Acid (75 mL) was cooled to ca. -40 oC. 6,7-
Dimethoxy-4-methylquinoline (4.0 g, 0.020 mol) was added to the 
reaction mixture in portions over 1 h, keeping the temperature at -
40 oC. The reaction was then stirred for an hour, also maintaining 
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the temperature at -40 oC. The reaction mixture was then poured over an ice-slurry and 
basified to pH 12 (50% w/v NaOH solution) in an ice bath of ice/salt (ca. -10 oC). The mixture 
did heat up as the base was added a bit too rapidly, causing concern for dinitration. The 
work-up was continued, the product was then rigorously extracted with CH2Cl2 (5 x 100 mL) 
and the solvent removed under reduced pressure to give 3.84 g of product (79% Yield). 1H 
NMR (400 MHz, CDCl3) δ 8.69 (d, J = 4.5 Hz, 1H), 7.75 (s, 1H), 7.21 (d, J = 4.5 Hz, 1H), 
4.09 (s, 3H), 4.05 (s, 3H), 2.59 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 153.8, 150.3, 145.9, 
142.5, 141.3, 141.0, 123.8, 115.1, 111.8, 62.9, 56.6, 18.6.40 Spectrum compares well to 
spectrum reported in the literature. 
4.2.3 Experiments pertaining to Section 2.2.3 – Oxidation of the 
aromatic methyl group (83) 
4.2.3.1 Synthesis of 6,7-Dimethoxy-5-nitroquinoline-4-carbaldehyde (83) 
6,7-Dimethoxy-4-methyl-5-nitroquinoline (1.6 g, 6.5 mmol) and 
Iron(III) chloride tetrahydrate (0.16 g, 0.81 mmol) was dissolved in 
DMSO (30 mL) at 60 oC. Trifluoroacetic acid (2.5 mL, 32 mmol), 
iodine (1.6 g, 6.4 mmol) and 2-iodo-2-methylpropane (1.5 mL, 13 
mmol) were then added to the reaction mixture in succession. The 
reaction was heated to 90 oC and stirred for 330 min. Analysis by TLC showed a spot at the 
same Rf (0.4 in 60% EtOAc/hexane) as the starting material. The reaction was adjudged to 
have reached completion. The reaction mixture was then poured into a stirring solution of 
saturated Na2S2O3 (200 mL) to give a green coloured solution. The mixture was then further 
diluted with K2CO3 (100 mL, 10% w/v) and the reaction mixture turned dark orange. The 
product was then rigorously extracted CH2Cl2 (5 x 50 mL). This extract was then washed 
with water (150 mL) and dried over anhydrous MgSO4. Removal of the solvent still left a high 
boiling point liquid, so the residue was redissolved in CH2Cl2 (100 mL) and washed with 
more H2O (150 mL). The solvent was then removed under reduced pressure to give 1.52 g 
of product (90% Yield). 1H NMR (400 MHz, CDCl3) δ 10.20 (s, 1H), 8.97 (d, J = 4.3 Hz, 1H), 
7.78 (d, J = 4.6 Hz, 1H), 7.69 (s, 1H), 4.14 (s, 3H), 4.12 (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ 189.5, 155.0, 150.7, 146.5, 145.1, 140.1 137.8, 122.2, 112.6, 111.7, 63.2, 56.8.40 
Spectrum compares well to spectrum reported in the literature. 
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4.2.4 Experiments pertaining to Section 2.2.4 – Protection of the 
aldehyde (84a,b) 
4.2.4.1 Synthesis of 4-(dimethoxymethyl)-6,7-dimethoxy-5-nitroquinoline (84a) 
6,7-Dimethoxy-5-nitroquinoline-4-carbaldehyde (1.75 g, 
6.67 mmol) was dissolved in trimethyl orthoformate (50 
mL) and p-toluenesulfonic acid monohydrate (635 mg, 
3.34 mmol) was then added. The mixture was stirred for 
24 h at 100 oC and then quenched with saturated NaHCO3 solution (40 mL). The mixture 
was then extracted with EtOAc (2 x 50 mL), dried and the solvent removed to give 1.96 g of 
pure product (92%). 1H NMR (300 MHz, CDCl3) δ 8.88 (d, J = 4.6 Hz, 1H), 7.88 (s, 1H), 7.84 
(d, J = 4.6 Hz, 1H), 5.60 (s, 1H), 4.09 (s, 3H), 4.07 (s, 3H), 3.41 (s, 3H), 3.40 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 152.6, 149.1, 145.4, 143.1, 139.7, 127.0, 124.6, 112.8, 111.9, 99.9, 
62.8, 56.4, 54.0.40 Spectrum compares well to spectrum reported in the literature. 
4.2.4.2 Synthesis of 4-(1,3-dioxolan-2-yl)-6,7-dimethoxy-5-nitroquinoline (84b) 
 6,7-Dimethoxy-5-nitroquinoline-4-carbaldehyde (1.00 g, 3.81 
mmol) was dissolved in dry benzene (20 mL) and ethylene glycol 
(0.43 mL, 7.6 mol) was added to the stirring solution. p-
Toluenesulfonic acid monohydrate (0.725 g, 3.81 mmol) was then 
added and the mixture was heated at reflux in a Dean-Stark 
apparatus. Reaction was stirred for 72 hours and then 
concentrated under reduced pressure. The residue was dissolved in 10% w/v K2CO3 (100 
mL) and EtOAc (100 mL) and the organic layer collected. The solvent was removed to give 
0.912 g of pure product, which did not require any further purification (79%). 1H NMR (400 
MHz, CDCl3) δ 8.83 (d, J = 4.6 Hz, 1H), 7.76 (dd, J = 4.6, 0.6 Hz, 1H), 7.66 (s, 1H), 6.18 (s, 
1H), 4.04 (s, 3H), 4.03 (s, 3H), 4.00 – 3.94 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 152.8, 
149.1, 145.1, 143.0, 139.7, 117.3, 112.2, 111.4, 98.5, 64.1, 61.8, 55.4. IR (ATR, cm-1) 3383, 
2943, 2891, 1538, 1489, 1472, 1455, 1418, 1402, 1353, 1325, 1246, 1196, 1091, 1053, 
1001, 968, 949, 936, 888, 859, 763. HRMS: calcd for C14H15N2O6+ [M+H]+, 307,0930 – found 
307.0932. 
 
Stellenbosch University  https://scholar.sun.ac.za
79 
 
4.2.5 Experiments pertaining to Section 2.2.5 – Reduction, ring-
closure and selective methylation (85,a,b-86) 
4.2.5.1 Synthesis of 4-(dimethoxymethyl)-6,7-dimethoxy-1,2,3,4-
tetrahydroquinolin-5-amine (85a) 
 4-(1,3-Dimethoxymethyl)-6,7-dimethoxy-5-nitroquinoline 
(743 mg, 2.41 mmol) and NiCl2.6H2O (6.87 g, 28.9 mmol) 
were rapidly stirred in methanol (90 mL). NaBH4 (6.47 g, 
0.171 mol) was crushed using a mortar and pestle and 
then added to the reaction in portions. Upon the addition of 
the first portion, the reaction mixture turned black due to a precipitate. The reaction was 
highly exothermic and the temperature increased to ca. 80 oC. After ca. 20 min, the reaction 
was quenched by adding distilled water (100 mL). The product was then extracted with 
EtOAc (3 x 50 mL) and the EtOAc layer dried over anhydrous MgSO4. The solid was filtered 
off and the EtOAc removed. The oily residue was redissolved in CH2Cl2 (40 mL), transferred 
to a smaller round bottomed flask and concentrated under reduced pressure to give 578.7 
mg of pure product (85% yield). 1H NMR (300 MHz, DMSO-d6) δ 5.52 (s, 1H), 4.56 (d, J = 
8.1 Hz, 1H), 3.87 (s, 3H), 3.75 (s, 3H), 3.41 (s, 3H), 3.36 (s, 3H), 3.20 – 3.16 (m, 2H), 2.21 (t, 
J = 4.7 Hz, 2H), 1.66 (m, 1H). 13C NMR (101 MHz, DMSO-d6) δ 152.3, 142.2, 141.0, 127.2, 
107.1, 97.5, 88.4, 65.3, 64.4, 60.2, 55.6, 37.3, 35.3, 23.4.40 Compound was difficult to 
dissolve in CDCl3, so spectrum was obtained in DMSO-d6.Despite different solvents, 1H 
NMR spectrum correlates well to spectrum reported in the literature. 13C NMR not reported in 
literature. 
4.2.5.2 Synthesis of 4-(1,3-dioxolan-2-yl)-6,7-dimethoxy-1,2,3,4-
tetrahydroquinolin-5-amine (85b) 
4-(1,3-Dioxolanyl)-6,7-dimethoxy-5-nitroquinoline (200 mg, 0.663 
mmol) and NiCl2.6H2O (1.9 g, 7.8 mmol) were rapidly stirred in 
methanol (15 mL). Sodium borohydride (1.76 g, 46.2 mmol) was 
crushed using a mortar and pestle and then added to the reaction 
in portions. Upon the addition of the first portion, the reaction 
mixture turned black due to a precipitate. Highly exothermic 
reaction, addition of the powdered sodium borohydride was too rapid and the reaction boiled 
over. After about 20 min, the reaction was then quenched by adding distilled water (20 mL). 
The product was then extracted with EtOAc (3 x 10 mL) and the EtOAc layer dried over 
anhydrous MgSO4. The solid was filtered off and the EtOAc removed. The oily residue was 
redissolved in CH2Cl2 (10 mL), transferred to a smaller round bottomed flask and 
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concentrated under reduced pressure to give 133.3 mg of pure product (73% yield). 1H NMR 
(400 MHz, CDCl3) δ 5.50 (d, J = 1.4 Hz, 1H), 4.88 (dd, J = 6.0, 1.5 Hz, 1H), 3.94 – 3.85 (m, 
2H), 3.79 – 3.72 (m, 2H), 3.70 – 3.65 (m, 6H), 3.52 – 3.45 (m, 1H), 3.36 – 3.27 (m, 1H), 3.21 
– 3.12 (m, 2H), 2.98 (t, J = 4.9 Hz, 1H). 13C NMR (101 MHz, CDCl3) δ 152.5, 141.3, 140.9, 
128.5, 107.9, 98.6, 88.9, 65.5, 64.5, 60.5, 55.6, 37.9, 35.5, 23.6. IR (ATR, cm-1) 3401, 2930, 
2890, 1506, 1464, 1423, 1355, 1293, 1237, 1202, 1114, 1086, 1016, 952, 788, 732. HRMS: 
calcd for C14H21N2O4+ [M+H]+, 281.1501 – found 281.1498. 
4.2.5.3 Synthesis of 7,8-dimethoxy-1,3,4,5-tetrahydropyrrolo[4,3,2-de]quinoline 
(86) 
4-(1,3-Dioxolanyl)-6,7-dimethoxy-5-nitroquinoline (0.500 g, 1.63 
mmol) and NiCl2.6H2O (4.6 g, 20 mmol) were rapidly stirred in 
methanol (50 mL). NaBH4 (3.48 g, 92.1 mmol) was then added to 
the reaction and upon addition of the first portion, the reaction 
mixture turned black due to a precipitate. The reaction was highly exothermic and a lot of 
gas was formed. After ca. 20 min, the reaction stopped bubbling and the reaction mixture 
was then quenched by adding distilled water (100 mL). The reaction mixture was filtered to 
remove the black precipitate and then transferred into a separation funnel. The mixture was 
extracted with CH2Cl2 (3 x 50 mL) and the solvent removed. The residue was immediately 
dissolved in 2N HCl (15 mL) and then heated to 60 oC. After 3 hours, the reaction mixture 
was neutralized with saturated NaHCO3 (75 mL) and extracted with CH2Cl2 (3 x 30 mL). 
Removal of the solvent gave 270 mg of impure product, which was purified by column 
chromatography. The spot at Rf 0.19 was collected to afford the desired product (66 mg, 
19% yield). 1H NMR (400 MHz, CDCl3) δ 6.98 (2 x s, 1H), 6.21 (2 x s, 1H), 4.26 (2 x t, J = 
7.9, 2H), 3.95 (2 x s, 3H), 2.89 (2 x t, J = 7.9, 2H). 13C NMR (101 MHz, CDCl3) δ 175.66, 
163.49, 161.76, 128.95, 128.07, 126.07, 121.52, 110.90, 61.32, 55.74, 23.33. 40 Spectrum 
showed unexplained doubling of all signals. These still compare reasonably well to literature 
values, considering that literature spectrum was reported in CDCl3 and experimental data 
collected in CDCl3/DMSO-d6 due to limited solubility of compound.40 
4.2.5.4 Synthesis of acetic formic anhydride 
Acetyl chloride (10 mL, 0.14 mol) was stirred in dry THF (10 mL) at 0 
oC and sodium formate (10 g, 0.22 mol) was added to the mixture. A 
condenser was attached to the reaction vessel and stirred for 6 
hours. The solid was then filtered off and the filtrate was stored in the freezer.60 
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4.2.6 Experiments pertaining to Section 2.2.7 – Methylation of the 
quinoline (111) 
4.2.6.1 Synthesis of 4-(dimethoxymethyl)-6,7-dimethoxy-1-methyl-5-
nitroquinolin-1-ium iodide (111) 
4-(1,3-Dimethoxymethyl)-6,7-dimethoxy-5-nitroquinoline 
(1.83 g, 6.06 mmol) was dissolved in toluene (20 mL). 
Methyl iodide (30 mL, 4.8 mol) was added and the mixture 
heated to 35 oC and stirred for 5 days. Product started 
precipitating out of solution and depositing on the walls of 
the round bottom flask. The reaction mixture poured off and diluted with hexane. The mixture 
went murky and when left for 3 days, crystals formed. The solvent was decanted and the 
deposit was dried under high vacuum and collected as an orange powder, giving 1.20 g of 
the desired product (44%). 1H NMR (300 MHz, DMSO-d6) δ 9.55 (d, J = 6.3 Hz, 1H), 8.28 (d, 
J = 6.2 Hz, 1H), 8.02 (s, 1H), 5.62 (s, 1H), 4.71 (s, 3H), 4.31 (s, 3H), 4.11 (s, 3H), 3.43 (s, 
3H), 3.40 (s, 3H). 13C NMR (151 MHz, DMSO-d6) δ 160.3, 152.6, 148.7, 143.2, 140.6, 140.4, 
131.0, 128.4, 123.2, 117.5, 66.3, 61.4, 57.3, 50.1, 23.8.40 Literature spectrum was run in 
acetone-d6, experimental data obtained in DMSO-d6, but despite this there is a strong 
correlation between the results. 13C NMR spectrum not reported in literature.    
4.2.7 Experiments pertaining to Section 2.2.8 – Reduction and 
ring-closure of the quinolinium species (112 & 87) 
4.2.7.1 Synthesis of 4-(dimethoxymethyl)-6,7-dimethoxy-1-methyl-1,2,3,4-
tetrahydroquinolin-5-amine (112) 
4-(dimethoxymethyl)-6,7-dimethoxy-1-methyl-5-
nitroquinolin-1-ium iodide (690 mg, 1.53 mmol) and 
NiCl2.6H2O (4.37 g, 18.4 mmol) were rapidly stirred in 
methanol (50 mL). Sodium borohydride (4.11 g, 0.109 mol) 
was crushed using a mortar and pestle and then added to 
the reaction in portions. Upon the addition of the first portion, the reaction mixture turned 
black due to a precipitate. Highly exothermic reaction, addition of the powdered sodium 
borohydride was too rapid and the reaction boiled over. After 35 min, the reaction was then 
quenched by adding distilled water (50 mL). The product was then extracted with EtOAc (3 x 
50 mL) and the EtOAc layer dried over anhydrous MgSO4. The solid was filtered off and the 
EtOAc removed in vacuo. The oily residue was redissolved in CH2Cl2 (50 mL), transferred to 
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a smaller round bottomed flask and concentrated under reduced pressure to give 419 mg of 
pure product (92% yield). 1H NMR (600 MHz, DMSO-d6) δ 5.71 (s, 1H), 4.36 (d, J = 7.8 Hz, 
1H), 3.72 (s, 3H), 3.56 (s, 3H), 3.30 (s, 3H), 3.22 (s, 3H), 3.21 – 3.18 (m, 1H), 3.04 (d, J = 
11.6, 3.5 Hz, 1H), 2.98 – 2.94 (m, 1H), 2.82 (s, 3H), 2.81 – 2.78 (m, 1H). 13C NMR (151 
MHz, DMSO-d6) δ 154.4, 145.6, 131.1, 128.6, 110.3, 103.6, 90.3, 62.8, 59.3, 58.2, 55.4, 
49.5, 37.4, 25.9. IR (ATR, cm-1) 3434, 3351, 2929, 2826, 2361, 2341, 1508, 1451, 1426, 
1396, 1341, 1308, 1264, 1228, 1197, 1051, 1019, 962, 891, 778, 735, 708. HRMS: calcd for 
C14H21N2O4+ [M+H]+, 297.1814 – found 297.1815. 
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